<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="jcsm13796" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cachexia Sarcopenia Muscle</journal-id><journal-id journal-id-type="iso-abbrev">J Cachexia Sarcopenia Muscle</journal-id><journal-id journal-id-type="doi">10.1007/13539.2190-6009</journal-id><journal-id journal-id-type="publisher-id">JCSM</journal-id><journal-title-group><journal-title>Journal of Cachexia, Sarcopenia and Muscle</journal-title></journal-title-group><issn pub-type="ppub">2190-5991</issn><issn pub-type="epub">2190-6009</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11972690</article-id><article-id pub-id-type="doi">10.1002/jcsm.13796</article-id><article-id pub-id-type="publisher-id">JCSM13796</article-id><article-id pub-id-type="other">JCSM-D-24-01226</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Association of Dietary Choline Intake With Incidence of Frailty: A Nationwide Prospective Cohort Study From China</article-title></title-group><contrib-group><contrib id="jcsm13796-cr-0001" contrib-type="author"><name><surname>Chen</surname><given-names>Lian&#x02010;hong</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0002" contrib-type="author"><name><surname>Zhong</surname><given-names>Jian&#x02010;feng</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0003" contrib-type="author"><name><surname>Niu</surname><given-names>Ying&#x02010;ying</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0004" contrib-type="author"><name><surname>Li</surname><given-names>Cheng&#x02010;ping</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0005" contrib-type="author"><name><surname>Li</surname><given-names>Jing</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0006" contrib-type="author"><name><surname>Diao</surname><given-names>Zhi&#x02010;quan</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0007" contrib-type="author"><name><surname>Yan</surname><given-names>Hao&#x02010;yu</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0008" contrib-type="author"><name><surname>Xu</surname><given-names>Miao</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0009" contrib-type="author"><name><surname>Huang</surname><given-names>Wen&#x02010;qi</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0010" contrib-type="author"><name><surname>Xu</surname><given-names>Zhi&#x02010;tong</given-names></name><xref rid="jcsm13796-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcsm13796-cr-0011" contrib-type="author"><name><surname>Su</surname><given-names>Chang</given-names></name><xref rid="jcsm13796-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="jcsm13796-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jcsm13796-cr-0012" contrib-type="author" corresp="yes"><name><surname>Liu</surname><given-names>Dan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-6245-6027</contrib-id><xref rid="jcsm13796-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><address><email>liudan0717@smu.edu.cn</email></address></contrib></contrib-group><aff id="jcsm13796-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Public Health and Preventive Medicine, School of Medicine</named-content>
<institution>Jinan University</institution>
<city>Guangzhou</city>
<named-content content-type="country-part">Guangdong</named-content>
<country country="CN">China</country>
</aff><aff id="jcsm13796-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">National Institute for Nutrition and Health</named-content>
<institution>Chinese Center for Disease Control and Prevention</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="jcsm13796-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Key Laboratory of Trace Element Nutrition</named-content>
<institution>National Health Commission</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="jcsm13796-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Epidemiology, School of Public Health</named-content>
<institution>Southern Medical University</institution>
<city>Guangzhou</city>
<named-content content-type="country-part">Guangdong</named-content>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Dan Liu (<email>liudan0717@smu.edu.cn</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>16</volume><issue seq="650">2</issue><issue-id pub-id-type="doi">10.1002/jcsm.v16.2</issue-id><elocation-id>e13796</elocation-id><history>
<date date-type="rev-recd"><day>12</day><month>2</month><year>2025</year></date>
<date date-type="received"><day>21</day><month>10</month><year>2024</year></date>
<date date-type="accepted"><day>27</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The Author(s). Journal of Cachexia, Sarcopenia and Muscle published by Wiley Periodicals LLC.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Journal of Cachexia, Sarcopenia and Muscle</italic> published by Wiley Periodicals LLC.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JCSM-16-e13796.pdf"/><abstract><title>ABSTRACT</title><sec id="jcsm13796-sec-0001"><title>Background</title><p>Emerging evidence suggests that dietary choline is a modifiable nutritional factor linked to various health outcomes. However, most existing studies have focused on isolated health conditions, lacking a comprehensive assessment of overall health status. This study aimed to investigate the association between total dietary choline intake and frailty incidence among Chinese adults, considering its derivatives, soluble forms (water&#x02010;soluble and lipid&#x02010;soluble) and food sources (animal&#x02010;derived and plant&#x02010;derived).</p></sec><sec id="jcsm13796-sec-0002"><title>Methods</title><p>Participants without frailty at baseline were enrolled from the China Health and Nutrition Survey (CHNS), with follow&#x02010;up from 2004 to 2016. Dietary intake was assessed using three consecutive 24&#x02010;h dietary recalls to estimate total dietary choline intake, its derivatives, soluble forms and food sources. Frailty status was evaluated using a frailty index (FI), with frailty defined as an FI&#x02009;&#x0003e;&#x02009;0.21. Cox proportional hazards regression and restricted cubic splines were used to analyse the associations between dietary choline intake and frailty incidence.</p></sec><sec id="jcsm13796-sec-0003"><title>Results</title><p>A total of 10 310 participants (mean age: 46.4&#x02009;years [SD: 14.5]; 52.6% female) were eligible. During a median follow&#x02010;up of 6.1&#x02009;years, 1150 incident frailty cases were recorded. Cox models with penalized splines showed an L&#x02010;shaped association between total dietary choline intake and frailty incidence. Compared with participants in the lowest quartile of total choline intake, those in the 2nd to 4th quartiles had lower odds of frailty, with hazard ratios (HRs) of 0.84 (95% CI: 0.71, 0.98), 0.80 (95% CI: 0.67, 0.95) and 0.75 (95% CI: 0.61, 0.93), respectively. Intake of lipid&#x02010;soluble choline in the 2nd to 4th quartiles was associated with an 18% (HR: 0.82; 95% CI: 0.69, 0.98) to 23% (HR: 0.77; 95% CI: 0.63, 0.95) reduction in the odds of frailty. Participants in the 3rd to 4th quartiles of phosphatidylcholine intake exhibited 19% (HR: 0.81; 95% CI: 0.68, 0.96) to 23% (HR: 0.77; 95% CI: 0.63, 0.94) lower odds of frailty. Choline intake from plant&#x02010;derived food sources was significantly associated with reduced odds of frailty (HR: 0.83; 95% CI: 0.69, 0.99).</p></sec><sec id="jcsm13796-sec-0004"><title>Conclusions</title><p>Moderate to high dietary choline intake (171.00&#x02013;464.99&#x02009;mg/day), particularly phosphatidylcholine (145.20&#x02013;304.93&#x02009;mg/day), may be associated with reduced odds of frailty.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jcsm13796-kwd-0001">cohort study</kwd><kwd id="jcsm13796-kwd-0002">dietary choline</kwd><kwd id="jcsm13796-kwd-0003">frailty</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82003443</award-id></award-group><award-group id="funding-0002"><funding-source>Construction of High&#x02010;level University of Guangdong</funding-source><award-id>G624330422</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="3"/><page-count count="13"/><word-count count="8700"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:06.04.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jcsm13796-ntgp-0001"><fn fn-type="funding" id="jcsm13796-note-0001"><p>
<bold>Funding:</bold> This work was supported by the National Natural Science Foundation of China (82003443) and the Construction of High&#x02010;level University of Guangdong (G624330422).</p></fn></fn-group></notes></front><body id="jcsm13796-body-0001"><sec id="jcsm13796-sec-0005"><label>1</label><title>Introduction</title><p>Frailty, an age&#x02010;associated clinical condition, is characterized by diminished physiological capacities, compromised biological mechanisms and heightened vulnerability to adverse health outcomes, such as morbidity, mortality, cognitive impairment, physical disability and increased healthcare expenditures [<xref rid="jcsm13796-bib-0001" ref-type="bibr">1</xref>]. A meta&#x02010;analysis revealed a frailty prevalence of 12%, reaching 24% based on the deficit accumulation model; for pre&#x02010;frailty, these figures were 46% and 49%, respectively [<xref rid="jcsm13796-bib-0002" ref-type="bibr">2</xref>]. Frailty has emerged as a significant public health concern amid global population aging [<xref rid="jcsm13796-bib-0003" ref-type="bibr">3</xref>]. However, frailty is a dynamic transition that is demonstrated to possess mutability and reversibility [<xref rid="jcsm13796-bib-0004" ref-type="bibr">4</xref>]. Therefore, identifying modifiable risk factors and developing interventions to prevent, delay or reverse frailty progression is crucial for public health [<xref rid="jcsm13796-bib-0005" ref-type="bibr">5</xref>].</p><p>Several studies suggest that nutrient substances are potentially modifiable contributors to the risk and prevention of frailty [<xref rid="jcsm13796-bib-0006" ref-type="bibr">6</xref>]. Choline, an essential nutrient, is crucial for the biosynthesis of neurotransmitters and the formation of phospholipids integral to cell membrane structure&#x000a0;[<xref rid="jcsm13796-bib-0007" ref-type="bibr">7</xref>]. Previous studies have demonstrated beneficial associations between choline and multiple health outcomes. The Framingham Heart Study showed that low choline intake is associated with an elevated risk of dementia and Alzheimer's disease [<xref rid="jcsm13796-bib-0008" ref-type="bibr">8</xref>]. Another cohort study suggested that choline and choline&#x02010;rich foods have protective effects against hypertension [<xref rid="jcsm13796-bib-0009" ref-type="bibr">9</xref>]. However, these studies typically focus on singular health outcomes, limiting the evaluation of overall health status. Most studies also focused exclusively on choline, overlooking its subtypes. Moreover, no cohort studies have examined the association between choline and frailty. Most epidemiological research on frailty excludes individuals under the age of 65, but frailty may be significant in the adult population as well [<xref rid="jcsm13796-bib-0010" ref-type="bibr">10</xref>].</p><p>Therefore, the present study aimed to explore the potential associations of choline and its subcategories intake and source (lipid&#x02010; and water&#x02010;soluble, animal&#x02010; and plant&#x02010;derived) with the incidence of pre&#x02010;frailty and frailty in Chinese adults. Our hypothesis posited that the choline consumption may have varying effects on the occurrence of pre&#x02010;frailty and frailty within this demographic.</p></sec><sec sec-type="methods" id="jcsm13796-sec-0006"><label>2</label><title>Methods</title><sec id="jcsm13796-sec-0007"><label>2.1</label><title>Study Design and Participants</title><p>The China Health and Nutrition Survey (CHNS) was a nationwide household&#x02010;based prospective cohort study, and the details of the study protocol have been described elsewhere [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S1</xref>]. Briefly, the CHNS was established in 1989 and included participants of diverse ages from nine provinces and three directly controlled municipalities (added in 2011). By 2011, the regions represented in the CHNS comprised 47% of China's overall population. The cohort employed a multistage random cluster sampling design to ensure representativeness. The survey focused on examining social demographic factors, nutritional and dietary status, physical activity and health outcomes.</p><p>This study used data from the 2004, 2006, 2009 and 2011 waves of the CHNS, as the survey has provided more reliable dietary data since 2004. The following participants were excluded: (1) 3807 participants who were less than 18&#x02009;years old at the baseline; (2) 188 participants who were pregnant; (3) 2037 participants who were without complete dietary data at the baseline; (4) 2422 participants with missing demographics, lifestyle or community index data; (5) 89 participants with implausible energy intake information (male: &#x0003c;&#x02009;800&#x02009;kcal/day or &#x0003e;&#x02009;6000&#x02009;kcal/day; female: &#x0003c;&#x02009;600&#x02009;kcal/day or &#x0003e;&#x02009;4000&#x02009;kcal/day); and (6) 465 participants with missing more than 20% of frailty index (FI) items (i.e., six or more items) at baseline [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S2</xref>]. A total of 13&#x02009;676 participants had a valid FI at baseline. The study was divided into three parts. First, we analysed the association between dietary choline intake and incident frailty. Participants with frailty (FI&#x02009;&#x0003e;&#x02009;0.21) at baseline (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1032) or those without follow&#x02010;up data (<italic toggle="yes">n</italic>&#x02009;=&#x02009;2334) were excluded, resulting in a final sample of 10&#x02009;310 participants. Second, we investigated the association between dietary choline intake and incident pre&#x02010;frailty. Participants with (pre&#x02010;) frailty (FI&#x02009;&#x0003e;&#x02009;0.1) at baseline (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4746), those who without follow&#x02010;up data (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1708) or those who developed new&#x02010;onset frailty during follow&#x02010;up (<italic toggle="yes">n</italic>&#x02009;=&#x02009;253) were excluded, leaving a total of 6969 participants. Third, we analysed the association between dietary choline intake and incident (pre&#x02010;) frailty. Participants with (pre&#x02010;) frailty (FI&#x02009;&#x0003e;&#x02009;0.1) at baseline (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4746) or those without follow&#x02010;up data (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1708) were excluded, resulting in 7222 participants included (Figure&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S1</xref>).</p><p>The CHNS is a collaborative project between the Carolina Population Center (CPC), University of North Carolina at Chapel Hill and the China National Institute of Nutrition and Food Safety at the Chinese Center for Disease Control and Prevention. Written informed consent was obtained from each CHNS participant, and the study was approved by the institutional review boards at the University of North Carolina at Chapel Hill (NC, USA) and the China National Institute of Nutrition and Food Safety at the Chinese Center for Disease Control and Prevention (Beijing, China).</p></sec><sec id="jcsm13796-sec-0008"><label>2.2</label><title>Assessment of Dietary Choline</title><p>The dietary data were obtained through three consecutive 24&#x02010;h dietary recalls (24h&#x02010;DRs) at the individual level, coupled with a household&#x02010;level weighting method of food inventory across the same three&#x02010;day period for each survey round [<xref rid="jcsm13796-bib-0011" ref-type="bibr">11</xref>]. The three consecutive days comprised two weekdays and one weekend day. The accuracy of 24h&#x02010;DRs in assessing energy and nutrient intake had been validated [<xref rid="jcsm13796-bib-0012" ref-type="bibr">12</xref>]. Well&#x02010;trained interviewers utilized food pictures and models to meticulously record the type and quantity of foods consumed daily. Participants self&#x02010;reported their consumption of all foods over the preceding three&#x02009;days. Due to the lack of available data on the choline and betaine content in the Chinese Food Composition Tables (CFCT), the values for these nutrients in the diet are based on the USDA database [<xref rid="jcsm13796-bib-0013" ref-type="bibr">13</xref>, <xref rid="jcsm13796-bib-0014" ref-type="bibr">14</xref>]. Total choline is composed of phosphatidylcholine, sphingomyelin, free choline, glycerophosphocholine and phosphocholine. Lipid&#x02010;soluble choline included phosphatidylcholine and sphingomyelin, while water&#x02010;soluble choline included free choline, glycerophosphocholine and phosphocholine [<xref rid="jcsm13796-bib-0015" ref-type="bibr">15</xref>]. Animal&#x02010; and plant&#x02010;derived choline intakes were calculated based on food sources. Dietary choline and betaine intakes were estimated by multiplying the quantity of each food item consumed by the nutrient content for a standard 100&#x02009;g portion size. The average daily intake over a three&#x02010;day period was calculated for each participant based on their total intake.</p></sec><sec id="jcsm13796-sec-0009"><label>2.3</label><title>Assessment of Frailty</title><p>The primary outcome of interest in this study was incident frailty. Frailty is commonly assessed using the FI, which is primarily based on the principle of cumulative deficits [<xref rid="jcsm13796-bib-0016" ref-type="bibr">16</xref>, <xref rid="jcsm13796-bib-0017" ref-type="bibr">17</xref>]. Different studies, including CKB, CHARLS, CLHLS, the UK Biobank and NHANES, have developed FI that include varying items [<xref rid="jcsm13796-bib-0018" ref-type="bibr">18</xref>, <xref rid="jcsm13796-bib-0019" ref-type="bibr">19</xref>, <xref rid="jcsm13796-bib-0020" ref-type="bibr">20</xref>, <xref rid="jcsm13796-bib-0021" ref-type="bibr">21</xref>, <xref rid="jcsm13796-bib-0022" ref-type="bibr">22</xref>]. In this study, we developed an FI that includes 27 items across six dimensions: history of chronic diseases (based on self&#x02010;reported physician diagnoses), symptoms experienced in the last 4&#x02009;weeks (based on self&#x02010;reported physician diagnoses), anthropometry indexes (measured by trained technicians using standard methods), health status (self&#x02010;reported), physical activity level (self&#x02010;reported) and sleep duration (self&#x02010;reported) (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S1</xref>). More details on the items of FI are provided in Supporting Information: Supplement Methods <xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">1</xref>. The FI is calculated as the ratio of the score of deficits exhibited by participants to the total score of potential deficits. For participants with missing data on certain deficits, we calculated the FI by excluding the absent items from both the numerator and the denominator. The FI score values range from 0 to 1, with a higher score indicating increased levels of frailty. According to the FI, participants were classified into three groups: non&#x02010;frailty (FI&#x02009;&#x02264;&#x02009;0.1), pre&#x02010;frailty (0.1&#x02009;&#x0003c;&#x02009;FI&#x02009;&#x02264;&#x02009;0.21) and frailty (FI&#x02009;&#x0003e;&#x02009;0.21) [<xref rid="jcsm13796-bib-0023" ref-type="bibr">23</xref>, <xref rid="jcsm13796-bib-0024" ref-type="bibr">24</xref>]. In our study, the term (pre&#x02010;) frailty refers to the combined states of pre&#x02010;frailty and frailty [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S3</xref>].</p></sec><sec id="jcsm13796-sec-0010"><label>2.4</label><title>Assessment of Covariates</title><p>Demographics, lifestyle and anthropometric characteristic data were collected through structured questionnaires at baseline, including age, sex, nationality, residence, geographical region, marital status, education, household per capita annual income, medical insurance, drinking, smoking, drinking water source, cooking fuel type, sedentary behaviour, dietary intake of energy, protein, fat and carbohydrate, body mass index (BMI), hypertension, health infrastructure score, sanitation score and social services score. Drinking was assessed through the question, &#x02018;Over the past year, what was your frequency and quantity of consumption of beer, wine, and liquor?&#x02019;. The alcohol concentration was consistent with previous study: beer&#x02009;=&#x02009;4%, wine&#x02009;=&#x02009;10% and liquor&#x02009;=&#x02009;38% (1 bottle&#x02009;=&#x02009;600&#x02009;mL, 1 Liang&#x02009;=&#x02009;50&#x02009;mL) [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S4</xref>]. Following WHO guidelines [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S5</xref>], low&#x02010;risk alcohol consumption was defined as &#x0003c;&#x02009;21&#x02009;g/day for females and &#x0003c;&#x02009;41&#x02009;g/day for males. We classified drinking into three categories: never (0&#x02009;g/day); moderate (1&#x02013;20&#x02009;g/day for females, 1&#x02013;40&#x02009;g/day for males); and excess (&#x02265;&#x02009;21&#x02009;g/day for females, &#x02265;&#x02009;41&#x02009;g/day for males). Smoking was categorized as never, previous and current. &#x02018;Never&#x02019; was defined as a negative response to the question, &#x02018;Have you ever smoked a cigarette?&#x02019;. &#x02018;Current&#x02019; was defined as an affirmative response to the question, &#x02018;Do you still smoke?&#x02019;. &#x02018;Previous&#x02019; referred to participants who had smoked in the past but were not currently smoking. Based on a prior study, we classified electricity, liquefied petroleum gas and natural gas as clean fuel, while coal, charcoal, kerosene, wood, straw and sticks were classified as polluting fuel [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S6</xref>]. Dietary intake (energy, protein, fat and carbohydrate) was estimated by calculating the product of the amount of each food item consumed and the nutrient composition for a standard portion size of 100&#x02009;g, as referenced in the CFCT [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S7&#x02010;S8</xref>]. BMI was calculated by dividing weight (kg) by height squared (m<sup>2</sup>). Hypertension was defined according to the following criteria: (1) mean systolic blood pressure (SBP)&#x02009;&#x02265;&#x02009;140&#x02009;mmHg and/or mean diastolic blood pressure (DBP)&#x02009;&#x02265;&#x02009;90&#x02009;mmHg; (2) self&#x02010;reported diagnosis of hypertension; (3) use of antihypertensive medication. Blood pressure was assessed three times with a standard mercury sphygmomanometer. We used the mean of measurements of SBP and DBP in our study. Scores for health infrastructure, sanitation and social services were used to assess urban features in China, based on an established urbanization scale [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S9</xref>]. These scores were derived from established algorithms, with a maximum of 10 points allocated. More details on the covariates are provided in Supporting Information: Supplement Methods <xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">2</xref>. Weight and height were measured by trained technicians utilizing standardized methods, while other covariates were self&#x02010;reported by participants.</p></sec><sec id="jcsm13796-sec-0011"><label>2.5</label><title>Statistical Analysis</title><p>Baseline characteristics are presented as numbers (percentage %) for categorical variables and the mean (standard deviation [SD]) for continuous variables. We used chi&#x02010;square tests (categorical variables) and analysis of variance and nonparametric Kruskal&#x02013;Wallis tests (continuous variables) to compare the baseline characteristics of participants according to quartiles of total choline intake.</p><p>Cox proportional hazards regression was utilized to estimate the hazard ratios (HRs) and corresponding 95% confidence intervals (95% CIs) for incident pre&#x02010;frailty and frailty with total choline and betaine. The proportional hazards assumption was tested using Schoenfeld residuals. Similar calculations were conducted to evaluate the relationships between lipid&#x02010; and water&#x02010;soluble choline, plant&#x02010; and animal&#x02010;derived choline and choline&#x02010;contributing compounds with incident pre&#x02010;frailty and frailty. Moreover, dose&#x02013;response relationships were analysed through nonparametrically restricted cubic spline regression, with knots positioned at the 5th, 35th, 65th and 95th percentiles, exploring the association of choline with incident pre&#x02010;frailty and frailty.</p><p>Several covariates were adjusted for in the analysis. Model 1 did not adjust any confounders. In Model 2, age (years, continuous), sex (female or male), nationality (Han or minority), residence (urban or rural), geographical region (northeastern China, eastern China, central China, southern China or southwestern China), marital status (married, single, or divorced, widowed or separated), education (at or below primary school, middle school, or at or above high school), household per capita annual income (CNY, continuous), medical insurance (yes or no), drinking (never, moderate, or excess), smoking (never, previous or current), drinking water source (tap water, well water or other), cooking fuel type (clean fuel or polluting fuel), sedentary behaviour (hours/day, continuous) and dietary intake of energy (kcal/day, continuous), protein (g/day, continuous), fat (g/day, continuous) and carbohydrate (g/day, continuous). In Model 3, adjustments were additionally made for BMI (kg/m<sup>2</sup>, continuous), hypertension (yes or no), health infrastructure score (continuous), sanitation score (continuous) and social services score (continuous).</p><p>Additionally, we conducted several subgroup and interaction analyses to explore potential variations. These analyses were stratified by sex (male and female), age group (18&#x02013;44, 45&#x02013;59 and &#x02265;&#x02009;60&#x02009;years) and energy intake (tertiles). To assess the robustness of our findings, we conducted several sensitivity analyses. Firstly, we excluded participants who experienced an outcome event in the first 2 or 4&#x02009;years of follow&#x02010;up to reduce potential reverse causality. Secondly, we excluded participants with (pre&#x02010;) frailty at baseline to confirm the stability of the frailty definition. Thirdly, to adjust for potential time&#x02010;varying confounding, we additionally adjusted for the survey year in the three models we constructed. Fourthly, to ensure the results were not influenced by variations in energy intake, we utilized energy adjustment models to calibrate the total choline intake [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S10</xref>]. Finally, we further adjusted for lipid profiles to assess the impact of lipid levels on frailty; additional details regarding the analyses are presented in Supporting Information: Supplement Methods <xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">3</xref>.</p><p>Analyses were conducted using R Version 4.3.1. All statistical tests were two&#x02010;tailed, and <italic toggle="yes">p</italic>&#x02010;values less than 0.05 were considered statistically significant.</p></sec></sec><sec sec-type="results" id="jcsm13796-sec-0012"><label>3</label><title>Results</title><sec id="jcsm13796-sec-0013"><label>3.1</label><title>Baseline Characteristics</title><p>The baseline characteristics of participants stratified by quartiles of total choline intake are presented in Table&#x000a0;<xref rid="jcsm13796-tbl-0001" ref-type="table">1</xref>. At baseline, the mean age was 46.4&#x02009;years (SD 14.5), with 5420 (52.6%) being female. Participants with higher total choline intake were more likely to have elevated educational levels, higher income, increased BMI, a higher prevalence of hypertension, higher community index scores and greater intakes of energy, protein, fat and carbohydrate. Additionally, they were more likely to be currently married, engage in greater leisure sedentary time, reside in urban areas, never smoke, never drink, use tap water, have medical insurance, and utilize clean fuel. The mean (SD) intake of total choline and betaine was 245.3 (SD 212.0) mg/day and 113.5 (SD 102.8) mg/day, respectively. The intake of choline&#x02010;contributing compounds, including phosphatidylcholine, sphingomyelin, free choline, glycerophosphocholine and phosphocholine, was 144.0 (SD 161.3) mg/day, 9.8 (SD 7.7) mg/day, 64.2 (SD 48.6) mg/day, 20.4 (SD 17.2) mg/day and 7.0 (SD 4.2) mg/day, respectively. Participants displayed comparable baseline characteristics in the (pre&#x02010;) frailty analysis (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S2</xref>).</p><table-wrap position="float" id="jcsm13796-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Baseline characteristics of participants by quartiles of total choline intake.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" style="border-bottom:solid 1px #000000" align="left" valign="bottom" colspan="1">Characteristic</th><th align="center" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Total</th><th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Total choline intake quartiles</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">1</th><th align="center" valign="bottom" rowspan="1" colspan="1">2</th><th align="center" valign="bottom" rowspan="1" colspan="1">3</th><th align="center" valign="bottom" rowspan="1" colspan="1">4</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Participants, no. (%)</td><td align="center" valign="top" rowspan="1" colspan="1">10&#x02009;310 (100.0)</td><td align="center" valign="top" rowspan="1" colspan="1">2578 (25.0)</td><td align="center" valign="top" rowspan="1" colspan="1">2577 (25.0)</td><td align="center" valign="top" rowspan="1" colspan="1">2577 (25.0)</td><td align="center" valign="top" rowspan="1" colspan="1">2578 (25.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">46.4 (14.5)</td><td align="center" valign="top" rowspan="1" colspan="1">48.0 (15.4)</td><td align="center" valign="top" rowspan="1" colspan="1">46.3 (14.2)</td><td align="center" valign="top" rowspan="1" colspan="1">46.4 (14.1)</td><td align="center" valign="top" rowspan="1" colspan="1">44.9 (13.9)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">18&#x02013;44, no. (%)</td><td align="center" valign="top" rowspan="1" colspan="1">4815 (46.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1107 (42.9)</td><td align="center" valign="top" rowspan="1" colspan="1">1218 (47.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1205 (46.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1285 (49.8)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">45&#x02013;59, no. (%)</td><td align="center" valign="top" rowspan="1" colspan="1">3554 (34.5)</td><td align="center" valign="top" rowspan="1" colspan="1">850 (33.0)</td><td align="center" valign="top" rowspan="1" colspan="1">896 (34.7)</td><td align="center" valign="top" rowspan="1" colspan="1">916 (35.5)</td><td align="center" valign="top" rowspan="1" colspan="1">892 (34.6)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x02265;&#x02009;60, no. (%)</td><td align="center" valign="top" rowspan="1" colspan="1">1941 (18.8)</td><td align="center" valign="top" rowspan="1" colspan="1">621 (24.1)</td><td align="center" valign="top" rowspan="1" colspan="1">463 (18.0)</td><td align="center" valign="top" rowspan="1" colspan="1">456 (17.7)</td><td align="center" valign="top" rowspan="1" colspan="1">401 (15.6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female, no. (%)</td><td align="center" valign="top" rowspan="1" colspan="1">5420 (52.6)</td><td align="center" valign="top" rowspan="1" colspan="1">1509 (58.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1434 (55.6)</td><td align="center" valign="top" rowspan="1" colspan="1">1333 (51.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1144 (44.4)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Nationality, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Han</td><td align="center" valign="top" rowspan="1" colspan="1">9139 (88.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2179 (84.5)</td><td align="center" valign="top" rowspan="1" colspan="1">2283 (88.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2335 (90.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2342 (90.8)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Minority</td><td align="center" valign="top" rowspan="1" colspan="1">1171 (11.4)</td><td align="center" valign="top" rowspan="1" colspan="1">399 (15.5)</td><td align="center" valign="top" rowspan="1" colspan="1">294 (11.4)</td><td align="center" valign="top" rowspan="1" colspan="1">242 (9.4)</td><td align="center" valign="top" rowspan="1" colspan="1">236 (9.2)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Residence, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Rural</td><td align="center" valign="top" rowspan="1" colspan="1">6563 (63.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1992 (77.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1791 (69.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1559 (60.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1221 (47.4)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Urban</td><td align="center" valign="top" rowspan="1" colspan="1">3747 (36.3)</td><td align="center" valign="top" rowspan="1" colspan="1">586 (22.7)</td><td align="center" valign="top" rowspan="1" colspan="1">786 (30.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1018 (39.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1357 (52.6)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Geographical region, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Northeastern China</td><td align="center" valign="top" rowspan="1" colspan="1">2388 (23.2)</td><td align="center" valign="top" rowspan="1" colspan="1">397 (15.4)</td><td align="center" valign="top" rowspan="1" colspan="1">543 (21.1)</td><td align="center" valign="top" rowspan="1" colspan="1">641 (24.9)</td><td align="center" valign="top" rowspan="1" colspan="1">807 (31.3)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Eastern China</td><td align="center" valign="top" rowspan="1" colspan="1">2600 (25.2)</td><td align="center" valign="top" rowspan="1" colspan="1">429 (16.6)</td><td align="center" valign="top" rowspan="1" colspan="1">590 (22.9)</td><td align="center" valign="top" rowspan="1" colspan="1">755 (29.3)</td><td align="center" valign="top" rowspan="1" colspan="1">826 (32.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Central China</td><td align="center" valign="top" rowspan="1" colspan="1">1679 (16.3)</td><td align="center" valign="top" rowspan="1" colspan="1">472 (18.3)</td><td align="center" valign="top" rowspan="1" colspan="1">470 (18.2)</td><td align="center" valign="top" rowspan="1" colspan="1">394 (15.3)</td><td align="center" valign="top" rowspan="1" colspan="1">343 (13.3)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Southern China</td><td align="center" valign="top" rowspan="1" colspan="1">2065 (20.0)</td><td align="center" valign="top" rowspan="1" colspan="1">679 (26.3)</td><td align="center" valign="top" rowspan="1" colspan="1">577 (22.4)</td><td align="center" valign="top" rowspan="1" colspan="1">459 (17.8)</td><td align="center" valign="top" rowspan="1" colspan="1">350 (13.6)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Southwestern China</td><td align="center" valign="top" rowspan="1" colspan="1">1578 (15.3)</td><td align="center" valign="top" rowspan="1" colspan="1">601 (23.3)</td><td align="center" valign="top" rowspan="1" colspan="1">397 (15.4)</td><td align="center" valign="top" rowspan="1" colspan="1">328 (12.7)</td><td align="center" valign="top" rowspan="1" colspan="1">252 (9.8)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Marital status, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Married</td><td align="center" valign="top" rowspan="1" colspan="1">8840 (85.7)</td><td align="center" valign="top" rowspan="1" colspan="1">2172 (84.3)</td><td align="center" valign="top" rowspan="1" colspan="1">2202 (85.4)</td><td align="center" valign="top" rowspan="1" colspan="1">2224 (86.3)</td><td align="center" valign="top" rowspan="1" colspan="1">2242 (87.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Never married</td><td align="center" valign="top" rowspan="1" colspan="1">767 (7.4)</td><td align="center" valign="top" rowspan="1" colspan="1">175 (6.8)</td><td align="center" valign="top" rowspan="1" colspan="1">178 (6.9)</td><td align="center" valign="top" rowspan="1" colspan="1">186 (7.2)</td><td align="center" valign="top" rowspan="1" colspan="1">228 (8.8)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Divorced, widowed or separated</td><td align="center" valign="top" rowspan="1" colspan="1">703 (6.8)</td><td align="center" valign="top" rowspan="1" colspan="1">231 (9.0)</td><td align="center" valign="top" rowspan="1" colspan="1">197 (7.6)</td><td align="center" valign="top" rowspan="1" colspan="1">167 (6.5)</td><td align="center" valign="top" rowspan="1" colspan="1">108 (4.2)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Education, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">At or below primary school</td><td align="center" valign="top" rowspan="1" colspan="1">3859 (37.4)</td><td align="center" valign="top" rowspan="1" colspan="1">1392 (54.0)</td><td align="center" valign="top" rowspan="1" colspan="1">1020 (39.6)</td><td align="center" valign="top" rowspan="1" colspan="1">828 (32.1)</td><td align="center" valign="top" rowspan="1" colspan="1">619 (24.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Middle school</td><td align="center" valign="top" rowspan="1" colspan="1">4874 (47.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1041 (40.4)</td><td align="center" valign="top" rowspan="1" colspan="1">1242 (48.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1289 (50.0)</td><td align="center" valign="top" rowspan="1" colspan="1">1302 (50.5)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">At or above high school</td><td align="center" valign="top" rowspan="1" colspan="1">1577 (15.3)</td><td align="center" valign="top" rowspan="1" colspan="1">145 (5.6)</td><td align="center" valign="top" rowspan="1" colspan="1">315 (12.2)</td><td align="center" valign="top" rowspan="1" colspan="1">460 (17.9)</td><td align="center" valign="top" rowspan="1" colspan="1">657 (25.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Household per capita annual income (CNY), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">9019.3 (12&#x02009;418.7)</td><td align="center" valign="top" rowspan="1" colspan="1">5229.6 (8867.8)</td><td align="center" valign="top" rowspan="1" colspan="1">7964.0 (10&#x02009;647.7)</td><td align="center" valign="top" rowspan="1" colspan="1">10&#x02009;482.2 (13&#x02009;507.3)</td><td align="center" valign="top" rowspan="1" colspan="1">12&#x02009;401.5 (14&#x02009;613.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Medical insurance, no. (%)</td><td align="center" valign="top" rowspan="1" colspan="1">5045 (48.9)</td><td align="center" valign="top" rowspan="1" colspan="1">877 (34.0)</td><td align="center" valign="top" rowspan="1" colspan="1">1220 (47.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1385 (53.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1563 (60.6)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Drinking, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Never</td><td align="center" valign="top" rowspan="1" colspan="1">7366 (71.4)</td><td align="center" valign="top" rowspan="1" colspan="1">2030 (78.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1887 (73.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1791 (69.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1658 (64.3)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Moderate</td><td align="center" valign="top" rowspan="1" colspan="1">2269 (22.0)</td><td align="center" valign="top" rowspan="1" colspan="1">431 (16.7)</td><td align="center" valign="top" rowspan="1" colspan="1">546 (21.2)</td><td align="center" valign="top" rowspan="1" colspan="1">601 (23.3)</td><td align="center" valign="top" rowspan="1" colspan="1">691 (26.8)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Excess</td><td align="center" valign="top" rowspan="1" colspan="1">675 (6.5)</td><td align="center" valign="top" rowspan="1" colspan="1">117 (4.5)</td><td align="center" valign="top" rowspan="1" colspan="1">144 (5.6)</td><td align="center" valign="top" rowspan="1" colspan="1">185 (7.2)</td><td align="center" valign="top" rowspan="1" colspan="1">229 (8.9)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Smoking, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Never</td><td align="center" valign="top" rowspan="1" colspan="1">7051 (68.4)</td><td align="center" valign="top" rowspan="1" colspan="1">1831 (71.0)</td><td align="center" valign="top" rowspan="1" colspan="1">1822 (70.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1716 (66.6)</td><td align="center" valign="top" rowspan="1" colspan="1">1682 (65.2)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Previous</td><td align="center" valign="top" rowspan="1" colspan="1">352 (3.4)</td><td align="center" valign="top" rowspan="1" colspan="1">77 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">78 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">93 (3.6)</td><td align="center" valign="top" rowspan="1" colspan="1">104 (4.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Current</td><td align="center" valign="top" rowspan="1" colspan="1">2907 (28.2)</td><td align="center" valign="top" rowspan="1" colspan="1">670 (26.0)</td><td align="center" valign="top" rowspan="1" colspan="1">677 (26.3)</td><td align="center" valign="top" rowspan="1" colspan="1">768 (29.8)</td><td align="center" valign="top" rowspan="1" colspan="1">792 (30.7)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Drinking water source, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tap water</td><td align="center" valign="top" rowspan="1" colspan="1">8186 (79.4)</td><td align="center" valign="top" rowspan="1" colspan="1">1758 (68.2)</td><td align="center" valign="top" rowspan="1" colspan="1">2056 (79.8)</td><td align="center" valign="top" rowspan="1" colspan="1">2128 (82.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2244 (87.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Well water</td><td align="center" valign="top" rowspan="1" colspan="1">1844 (17.9)</td><td align="center" valign="top" rowspan="1" colspan="1">685 (26.6)</td><td align="center" valign="top" rowspan="1" colspan="1">461 (17.9)</td><td align="center" valign="top" rowspan="1" colspan="1">401 (15.6)</td><td align="center" valign="top" rowspan="1" colspan="1">297 (11.5)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Other</td><td align="center" valign="top" rowspan="1" colspan="1">280 (2.7)</td><td align="center" valign="top" rowspan="1" colspan="1">135 (5.2)</td><td align="center" valign="top" rowspan="1" colspan="1">60 (2.3)</td><td align="center" valign="top" rowspan="1" colspan="1">48 (1.9)</td><td align="center" valign="top" rowspan="1" colspan="1">37 (1.4)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Cooking fuel type, no. (%)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Clean fuel</td><td align="center" valign="top" rowspan="1" colspan="1">5787 (56.1)</td><td align="center" valign="top" rowspan="1" colspan="1">975 (37.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1374 (53.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1582 (61.4)</td><td align="center" valign="top" rowspan="1" colspan="1">1856 (72.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Polluting fuel</td><td align="center" valign="top" rowspan="1" colspan="1">4523 (43.9)</td><td align="center" valign="top" rowspan="1" colspan="1">1603 (62.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1203 (46.7)</td><td align="center" valign="top" rowspan="1" colspan="1">995 (38.6)</td><td align="center" valign="top" rowspan="1" colspan="1">722 (28.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sedentary behaviour (hours/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">1.8 (1.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1.7 (1.6)</td><td align="center" valign="top" rowspan="1" colspan="1">1.8 (1.4)</td><td align="center" valign="top" rowspan="1" colspan="1">1.8 (1.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1.8 (1.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">23.2 (3.4)</td><td align="center" valign="top" rowspan="1" colspan="1">22.7 (3.5)</td><td align="center" valign="top" rowspan="1" colspan="1">23.2 (3.3)</td><td align="center" valign="top" rowspan="1" colspan="1">23.4 (3.4)</td><td align="center" valign="top" rowspan="1" colspan="1">23.6 (3.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SBP (mmHg), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">121.0 (16.4)</td><td align="center" valign="top" rowspan="1" colspan="1">121.2 (17.5)</td><td align="center" valign="top" rowspan="1" colspan="1">120.4 (16.1)</td><td align="center" valign="top" rowspan="1" colspan="1">121.4 (16.9)</td><td align="center" valign="top" rowspan="1" colspan="1">120.9 (15.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DBP (mmHg), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">78.2 (10.3)</td><td align="center" valign="top" rowspan="1" colspan="1">78.0 (10.9)</td><td align="center" valign="top" rowspan="1" colspan="1">77.8 (10.3)</td><td align="center" valign="top" rowspan="1" colspan="1">78.5 (10.1)</td><td align="center" valign="top" rowspan="1" colspan="1">78.6 (10.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypertension, no. (%)</td><td align="center" valign="top" rowspan="1" colspan="1">5659 (54.9)</td><td align="center" valign="top" rowspan="1" colspan="1">1388 (53.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1396 (54.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1445 (56.1)</td><td align="center" valign="top" rowspan="1" colspan="1">1430 (55.5)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Dietary intake</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Energy (kcal/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">2085.0 (657.9)</td><td align="center" valign="top" rowspan="1" colspan="1">1842.4 (579.7)</td><td align="center" valign="top" rowspan="1" colspan="1">2002.3 (619.4)</td><td align="center" valign="top" rowspan="1" colspan="1">2130.9 (647.7)</td><td align="center" valign="top" rowspan="1" colspan="1">2364.2 (671.2)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Protein (g/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">65.8 (24.0)</td><td align="center" valign="top" rowspan="1" colspan="1">49.8 (15.5)</td><td align="center" valign="top" rowspan="1" colspan="1">60.7 (18.6)</td><td align="center" valign="top" rowspan="1" colspan="1">69.1 (21.3)</td><td align="center" valign="top" rowspan="1" colspan="1">83.6 (25.5)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Fat (g/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">70.4 (37.3)</td><td align="center" valign="top" rowspan="1" colspan="1">52.7 (30.1)</td><td align="center" valign="top" rowspan="1" colspan="1">65.6 (34.1)</td><td align="center" valign="top" rowspan="1" colspan="1">74.8 (35.6)</td><td align="center" valign="top" rowspan="1" colspan="1">88.5 (39.4)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Carbohydrate (g/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">293.9 (114.1)</td><td align="center" valign="top" rowspan="1" colspan="1">291.2 (109.9)</td><td align="center" valign="top" rowspan="1" colspan="1">290.0 (116.5)</td><td align="center" valign="top" rowspan="1" colspan="1">291.6 (117.2)</td><td align="center" valign="top" rowspan="1" colspan="1">302.7 (112.1)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Community index</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Health infrastructure score, mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">5.5 (2.4)</td><td align="center" valign="top" rowspan="1" colspan="1">4.9 (2.3)</td><td align="center" valign="top" rowspan="1" colspan="1">5.5 (2.3)</td><td align="center" valign="top" rowspan="1" colspan="1">5.5 (2.4)</td><td align="center" valign="top" rowspan="1" colspan="1">5.9 (2.4)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sanitation score, mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">6.9 (2.9)</td><td align="center" valign="top" rowspan="1" colspan="1">5.9 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">6.8 (2.9)</td><td align="center" valign="top" rowspan="1" colspan="1">7.3 (2.8)</td><td align="center" valign="top" rowspan="1" colspan="1">7.8 (2.6)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Social services score, mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">3.6 (3.1)</td><td align="center" valign="top" rowspan="1" colspan="1">2.9 (2.7)</td><td align="center" valign="top" rowspan="1" colspan="1">3.5 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">3.8 (3.1)</td><td align="center" valign="top" rowspan="1" colspan="1">4.2 (3.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total choline (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">245.3 (212.0)</td><td align="center" valign="top" rowspan="1" colspan="1">96.1 (26.7)</td><td align="center" valign="top" rowspan="1" colspan="1">171.0 (20.2)</td><td align="center" valign="top" rowspan="1" colspan="1">249.0 (26.0)</td><td align="center" valign="top" rowspan="1" colspan="1">465.0 (319.2)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Lipid&#x02010;soluble choline<xref rid="jcsm13796-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref> (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">153.8 (166.2)</td><td align="center" valign="top" rowspan="1" colspan="1">45.2 (21.7)</td><td align="center" valign="top" rowspan="1" colspan="1">98.8 (27.4)</td><td align="center" valign="top" rowspan="1" colspan="1">156.0 (38.1)</td><td align="center" valign="top" rowspan="1" colspan="1">314.8 (259.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Water&#x02010;soluble choline<xref rid="jcsm13796-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref> (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">91.6 (61.9)</td><td align="center" valign="top" rowspan="1" colspan="1">52.6 (16.9)</td><td align="center" valign="top" rowspan="1" colspan="1">73.7 (23.4)</td><td align="center" valign="top" rowspan="1" colspan="1">94.0 (32.6)</td><td align="center" valign="top" rowspan="1" colspan="1">145.9 (93.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Phosphatidylcholine (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">144.0 (161.3)</td><td align="center" valign="top" rowspan="1" colspan="1">41.3 (19.9)</td><td align="center" valign="top" rowspan="1" colspan="1">91.2 (25.5)</td><td align="center" valign="top" rowspan="1" colspan="1">145.5 (36.0)</td><td align="center" valign="top" rowspan="1" colspan="1">297.9 (254.4)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sphingomyelin (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">9.8 (7.7)</td><td align="center" valign="top" rowspan="1" colspan="1">3.9 (3.3)</td><td align="center" valign="top" rowspan="1" colspan="1">7.6 (4.3)</td><td align="center" valign="top" rowspan="1" colspan="1">10.9 (5.4)</td><td align="center" valign="top" rowspan="1" colspan="1">16.9 (9.2)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Free choline (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">64.2 (48.6)</td><td align="center" valign="top" rowspan="1" colspan="1">36.7 (14.3)</td><td align="center" valign="top" rowspan="1" colspan="1">51.8 (21.2)</td><td align="center" valign="top" rowspan="1" colspan="1">65.9 (29.5)</td><td align="center" valign="top" rowspan="1" colspan="1">102.3 (74.5)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Glycerophosphocholine (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">20.4 (17.2)</td><td align="center" valign="top" rowspan="1" colspan="1">11.0 (4.5)</td><td align="center" valign="top" rowspan="1" colspan="1">15.7 (6.4)</td><td align="center" valign="top" rowspan="1" colspan="1">20.5 (9.2)</td><td align="center" valign="top" rowspan="1" colspan="1">34.4 (27.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Phosphocholine (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">7.0 (4.2)</td><td align="center" valign="top" rowspan="1" colspan="1">5.0 (2.9)</td><td align="center" valign="top" rowspan="1" colspan="1">6.2 (3.3)</td><td align="center" valign="top" rowspan="1" colspan="1">7.5 (3.9)</td><td align="center" valign="top" rowspan="1" colspan="1">9.2 (5.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Betaine (mg/day), mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">113.5 (102.8)</td><td align="center" valign="top" rowspan="1" colspan="1">102.0 (101.9)</td><td align="center" valign="top" rowspan="1" colspan="1">109.4 (103.4)</td><td align="center" valign="top" rowspan="1" colspan="1">116.3 (97.3)</td><td align="center" valign="top" rowspan="1" colspan="1">126.2 (106.7)</td></tr></tbody></table><table-wrap-foot id="jcsm13796-ntgp-0002"><fn id="jcsm13796-note-0004"><p>
<italic toggle="yes">Note:</italic> The mean of three measurements of systolic and diastolic blood pressure was used.</p></fn><fn id="jcsm13796-note-0005"><p>Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.</p></fn><fn id="jcsm13796-note-0002"><label>
<sup>a</sup>
</label><p>Lipid&#x02010;soluble choline includes phosphatidylcholine and sphingomyelin.</p></fn><fn id="jcsm13796-note-0003"><label>
<sup>b</sup>
</label><p>Water&#x02010;soluble choline includes free choline, glycerophosphocholine and phosphocholine.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jcsm13796-sec-0014"><label>3.2</label><title>Dietary Choline and Betaine Intake With Pre&#x02010;Frailty and Frailty</title><p>Over a median of 6.1&#x02009;years (P<sub>25</sub>&#x02013;P<sub>75</sub>, 4.0&#x02013;11.0&#x02009;years) follow&#x02010;up, 1150 cases (11.2%) of incident frailty were recorded for the analysis of frailty. During a median follow&#x02010;up duration of 5.0&#x02009;years (P<sub>25</sub>&#x02013;P<sub>75</sub>, 3.1&#x02013;9.0&#x02009;years), 2376 cases (34.1%) of incident pre&#x02010;frailty were documented. For the analysis of (pre&#x02010;) frailty, across a median follow&#x02010;up period of 5.0&#x02009;years (P<sub>25</sub>&#x02013;P<sub>75</sub>, 3.0&#x02013;9.0&#x02009;years), 2629 cases (36.4%) of incident (pre&#x02010;) frailty were recorded (Figure&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S1</xref>).</p><p>Cox models with penalized splines showed statistically significant L&#x02010;shaped associations for total choline with pre&#x02010;frailty and frailty (Figure&#x000a0;<xref rid="jcsm13796-fig-0001" ref-type="fig">1</xref>). Table&#x000a0;<xref rid="jcsm13796-tbl-0002" ref-type="table">2</xref> presents the association of total choline intake with incident pre&#x02010;frailty and frailty. Categorizing total choline intake into quartiles, compared with the 1st quartile, those in the 2nd to 4th quartiles had lower frailty risks with HRs of 0.84 (95% CI: 0.71, 0.98), 0.80 (95% CI: 0.67, 0.95) and 0.75 (95% CI: 0.61, 0.93), respectively. Compared with those in the 1st quartile of total choline, participants in the 3rd quartile had lower odds, with HRs of 0.87 (95% CI: 0.77, 0.99) and 0.85 (95% CI: 0.76, 0.96) for pre&#x02010;frailty and (pre&#x02010;) frailty, respectively.</p><fig position="float" fig-type="FIGURE" id="jcsm13796-fig-0001"><label>FIGURE 1</label><caption><p>Dose&#x02010;respond associations of total choline intake with incident pre&#x02010;frailty and frailty. (a: associations of total choline intake with incident frailty; b: associations of total choline intake with incident pre&#x02010;frailty; c: associations of total choline intake with incident (pre&#x02010;) frailty). The term (pre&#x02010;) frailty refers to the combined states of pre&#x02010;frailty and frailty. Adjusted for age (years, continuous), sex (female or male), nationality (Han or minority), residence (urban or rural), geographical region (northeastern China, eastern China, central China, southern China or southwestern China), marital status (married, single, or divorced, widowed or separated), education (at or below primary school, middle school, or at or above high school), household per capita annual income (CNY, continuous), medical insurance (yes or no), drinking (never, moderate or excess), smoking (never, previous or current), drinking water source (tap water, well water or other), cooking fuel type (clean fuel fuel or polluting fuel), sedentary behaviour (hours/day, continuous), dietary intake of energy (kcal/day, continuous), protein (g/day, continuous), fat (g/day, continuous) and carbohydrate (g/day, continuous), body mass index (kg/m<sup>2</sup>, continuous), hypertension (yes or no), health infrastructure score (continuous), sanitation score (continuous) and social services score (continuous).</p></caption><graphic xlink:href="JCSM-16-e13796-g001" position="anchor" id="jats-graphic-1"/></fig><table-wrap position="float" id="jcsm13796-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Associations of total choline intake with incident pre&#x02010;frailty and frailty.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" style="border-bottom:solid 1px #000000" align="left" valign="bottom" colspan="1">Outcomes</th><th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Total choline intake quartiles</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">1</th><th align="center" valign="bottom" rowspan="1" colspan="1">2</th><th align="center" valign="bottom" rowspan="1" colspan="1">3</th><th align="center" valign="bottom" rowspan="1" colspan="1">4</th></tr></thead><tbody valign="top"><tr><td colspan="5" align="left" valign="top" rowspan="1">Frailty (<italic toggle="yes">n</italic>&#x02009;=&#x02009;10&#x02009;310)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/day</td><td align="center" valign="top" rowspan="1" colspan="1">96.14 (26.72)</td><td align="center" valign="top" rowspan="1" colspan="1">171.00 (20.24)</td><td align="center" valign="top" rowspan="1" colspan="1">249.03 (25.97)</td><td align="center" valign="top" rowspan="1" colspan="1">464.99 (319.20)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">368/2578</td><td align="center" valign="top" rowspan="1" colspan="1">276/2577</td><td align="center" valign="top" rowspan="1" colspan="1">264/2577</td><td align="center" valign="top" rowspan="1" colspan="1">242/2578</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Incidence rate per 1000 person&#x02010;years</td><td align="center" valign="top" rowspan="1" colspan="1">19.70</td><td align="center" valign="top" rowspan="1" colspan="1">15.77</td><td align="center" valign="top" rowspan="1" colspan="1">15.61</td><td align="center" valign="top" rowspan="1" colspan="1">14.82</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0006" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.81 (0.69, 0.95)</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 (0.68, 0.94)</td><td align="center" valign="top" rowspan="1" colspan="1">0.75 (0.64, 0.88)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0007" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.84 (0.72, 0.99)</td><td align="center" valign="top" rowspan="1" colspan="1">0.79 (0.66, 0.94)</td><td align="center" valign="top" rowspan="1" colspan="1">0.75 (0.61, 0.92)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0008" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.84 (0.71, 0.98)</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 (0.67, 0.95)</td><td align="center" valign="top" rowspan="1" colspan="1">0.75 (0.61, 0.93)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Pre&#x02010;frailty (<italic toggle="yes">n</italic>&#x02009;=&#x02009;6969)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/day</td><td align="center" valign="top" rowspan="1" colspan="1">98.64 (27.06)</td><td align="center" valign="top" rowspan="1" colspan="1">172.90 (19.98)</td><td align="center" valign="top" rowspan="1" colspan="1">250.09 (25.96)</td><td align="center" valign="top" rowspan="1" colspan="1">460.63 (250.90)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">666/1743</td><td align="center" valign="top" rowspan="1" colspan="1">597/1742</td><td align="center" valign="top" rowspan="1" colspan="1">550/1742</td><td align="center" valign="top" rowspan="1" colspan="1">563/1742</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Incidence rate per 1000 person&#x02010;years</td><td align="center" valign="top" rowspan="1" colspan="1">61.92</td><td align="center" valign="top" rowspan="1" colspan="1">58.25</td><td align="center" valign="top" rowspan="1" colspan="1">54.61</td><td align="center" valign="top" rowspan="1" colspan="1">58.44</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0006" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.94 (0.84, 1.05)</td><td align="center" valign="top" rowspan="1" colspan="1">0.88 (0.79, 0.98)</td><td align="center" valign="top" rowspan="1" colspan="1">0.93 (0.83, 1.04)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0007" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.87, 1.09)</td><td align="center" valign="top" rowspan="1" colspan="1">0.87 (0.77, 0.99)</td><td align="center" valign="top" rowspan="1" colspan="1">0.98 (0.85, 1.13)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0008" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 (0.86, 1.08)</td><td align="center" valign="top" rowspan="1" colspan="1">0.87 (0.77, 0.99)</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.84, 1.12)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">(Pre&#x02010;) frailty<xref rid="jcsm13796-note-0009" ref-type="table-fn">
<sup>d</sup>
</xref> (<italic toggle="yes">n</italic>&#x02009;=&#x02009;7222)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/day</td><td align="center" valign="top" rowspan="1" colspan="1">98.07 (26.93)</td><td align="center" valign="top" rowspan="1" colspan="1">171.94 (19.91)</td><td align="center" valign="top" rowspan="1" colspan="1">249.19 (26.01)</td><td align="center" valign="top" rowspan="1" colspan="1">459.43 (248.22)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">748/1806</td><td align="center" valign="top" rowspan="1" colspan="1">659/1805</td><td align="center" valign="top" rowspan="1" colspan="1">603/1805</td><td align="center" valign="top" rowspan="1" colspan="1">619/1806</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Incidence rate per 1000 person&#x02010;years</td><td align="center" valign="top" rowspan="1" colspan="1">68.09</td><td align="center" valign="top" rowspan="1" colspan="1">62.70</td><td align="center" valign="top" rowspan="1" colspan="1">58.26</td><td align="center" valign="top" rowspan="1" colspan="1">62.51</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0006" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.92 (0.83, 1.02)</td><td align="center" valign="top" rowspan="1" colspan="1">0.85 (0.76, 0.95)</td><td align="center" valign="top" rowspan="1" colspan="1">0.91 (0.82, 1.01)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0007" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 (0.86, 1.07)</td><td align="center" valign="top" rowspan="1" colspan="1">0.85 (0.76, 0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 (0.84, 1.10)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0008" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.95 (0.85, 1.06)</td><td align="center" valign="top" rowspan="1" colspan="1">0.85 (0.76, 0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">0.95 (0.83, 1.09)</td></tr></tbody></table><table-wrap-foot id="jcsm13796-ntgp-0003"><fn id="jcsm13796-note-0006"><label>
<sup>a</sup>
</label><p>The crude model was not adjusted for any confounders.</p></fn><fn id="jcsm13796-note-0007"><label>
<sup>b</sup>
</label><p>Adjusted for age (years, continuous), sex (female or male), nationality (Han or minority), residence (urban or rural), geographical region (northeastern China, eastern China, central China, southern China or southwestern China), marital status (married, single, or divorced, widowed or separated), education (at or below primary school, middle school, or at or above high school), household per capita annual income (CNY, continuous), medical insurance (yes or no), drinking (never, moderate or excess), smoking (never, previous or current), drinking water source (tap water, well water or other), cooking fuel type (clean fuel or polluting fuel), sedentary behaviour (hours/day, continuous), dietary intake of energy (kcal/day, continuous), protein (g/day, continuous), fat (g/day, continuous) and carbohydrate (g/day, continuous).</p></fn><fn id="jcsm13796-note-0008"><label>
<sup>c</sup>
</label><p>Additionally adjusted for body mass index (kg/m<sup>2</sup>, continuous), hypertension (yes or no), health infrastructure score (continuous), sanitation score (continuous) and social services score (continuous).</p></fn><fn id="jcsm13796-note-0009"><label>
<sup>d</sup>
</label><p>The term (pre&#x02010;) frailty refers to the combined states of pre&#x02010;frailty and frailty.</p></fn></table-wrap-foot></table-wrap><p>A negative dose&#x02013;response association of lipid&#x02010; and water&#x02010;soluble choline intake with incident pre&#x02010;frailty and frailty is shown in Figure&#x000a0;<xref rid="jcsm13796-fig-0002" ref-type="fig">2</xref>. Participants in the 2nd to 4th quartiles of lipid&#x02010;soluble choline exhibited 18% (HR: 0.82; 95% CI: 0.69, 0.98) to 23% (HR: 0.77; 95% CI: 0.63, 0.95) lower risks compared with the 1st quartile. Participants in the 3rd quartile of lipid&#x02010;soluble choline had lower pre&#x02010;frailty and (pre&#x02010;) frailty risks with HRs of 0.88 (95% CI: 0.77, 0.99) and 0.87 (95% CI: 0.77, 0.98) compared with the 1st quartile, respectively. Participants in the 2nd quartile of water&#x02010;soluble choline intake demonstrated lower odds compared with those in the 1st quartile, with HRs of 0.83 (95% CI: 0.74, 0.94) and 0.86 (95% CI: 0.77, 0.97) for pre&#x02010;frailty and (pre&#x02010;) frailty, respectively (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S3</xref>).</p><fig position="float" fig-type="FIGURE" id="jcsm13796-fig-0002"><label>FIGURE 2</label><caption><p>Dose&#x02010;respond associations of lipid&#x02010; and water&#x02010;soluble choline intake with incident pre&#x02010;frailty and frailty. (a, b: associations of lipid&#x02010; and water&#x02010;soluble choline intake with incident frailty; c, d: associations of lipid&#x02010; and water&#x02010;soluble choline intake with incident pre&#x02010;frailty; e, f: associations of lipid&#x02010; and water&#x02010;soluble intake choline with incident (pre&#x02010;) frailty). The term (pre&#x02010;) frailty refers to the combined states of pre&#x02010;frailty and frailty. Adjusted for age (years, continuous), sex (female or male), nationality (Han or minority), residence (urban or rural), geographical region (northeastern China, eastern China, central China, southern China or southwestern China), marital status (married, single, or divorced, widowed or separated), education (at or below primary school, middle school, or at or above high school), household per capita annual income (CNY, continuous), medical insurance (yes or no), drinking (never, moderate or excess), smoking (never, previous or current), drinking water source (tap water, well water or other), cooking fuel type (clean fuel fuel or polluting fuel), sedentary behaviour (hours/day, continuous), dietary intake of energy (kcal/day, continuous), protein (g/day, continuous), fat (g/day, continuous) and carbohydrate (g/day, continuous), body mass index (kg/m<sup>2</sup>, continuous), hypertension (yes or no), health infrastructure score (continuous), sanitation score (continuous) and social services score (continuous).</p></caption><graphic xlink:href="JCSM-16-e13796-g002" position="anchor" id="jats-graphic-3"/></fig><p>Subsequent analysis examined the relationship of choline&#x02010;contributing compounds with pre&#x02010;frailty and frailty. Consumption in the 3rd to 4th quartiles of phosphatidylcholine was associated with a 19% (HR: 0.81; 95% CI: 0.68, 0.96) to 23% (HR: 0.77; 95% CI: 0.63, 0.94) reduction in frailty risk compared with the 1st quartile (Table&#x000a0;<xref rid="jcsm13796-tbl-0003" ref-type="table">3</xref>, Figure&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S2</xref>). Our analysis indicated that consumption in the 3rd quartile of phosphatidylcholine (HR: 0.84; 95% CI: 0.74, 0.95) and sphingomyelin (HR: 0.84; 95% CI: 0.74, 0.96) was associated with a 16% reduction in the odds of pre&#x02010;frailty compared with the 1st quartile (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S4</xref>). Further investigation into the (pre&#x02010;) frailty showed that both phosphatidylcholine and sphingomyelin intake significantly reduced (pre&#x02010;) frailty risk, with HRs of 0.84 (95% CI: 0.75, 0.95) and 0.84 (95% CI: 0.75, 0.96), respectively (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S5</xref>). Participants in the 2nd quartile of betaine had obviously lower odds of incident pre&#x02010;frailty, with an HR of 0.86 (95% CI: 0.76, 0.97) (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S4</xref>).</p><table-wrap position="float" id="jcsm13796-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Associations of choline&#x02010;contributing compounds and betaine intake with incident frailty.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" style="border-bottom:solid 1px #000000" align="left" valign="bottom" colspan="1">Dietary choline and betaine</th><th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Choline&#x02010;contributing compounds and betaine intake quartiles</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">1</th><th align="center" valign="bottom" rowspan="1" colspan="1">2</th><th align="center" valign="bottom" rowspan="1" colspan="1">3</th><th align="center" valign="bottom" rowspan="1" colspan="1">4</th></tr></thead><tbody valign="top"><tr><td colspan="5" align="left" valign="top" rowspan="1">Phosphatidylcholine</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/day</td><td align="center" valign="top" rowspan="1" colspan="1">38.17 (15.58)</td><td align="center" valign="top" rowspan="1" colspan="1">87.72 (14.44)</td><td align="center" valign="top" rowspan="1" colspan="1">145.20 (19.94)</td><td align="center" valign="top" rowspan="1" colspan="1">304.93 (250.90)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">365/2578</td><td align="center" valign="top" rowspan="1" colspan="1">279/2577</td><td align="center" valign="top" rowspan="1" colspan="1">257/2577</td><td align="center" valign="top" rowspan="1" colspan="1">249/2578</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0010" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.86 (0.74, 1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">0.82 (0.70, 0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">0.84 (0.71, 0.99)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0011" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.83 (0.71, 0.98)</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 (0.67, 0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">0.75 (0.61, 0.92)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0012" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.85 (0.73, 1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">0.81 (0.68, 0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">0.77 (0.63, 0.94)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Sphingomyelin</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/day</td><td align="center" valign="top" rowspan="1" colspan="1">1.99 (1.51)</td><td align="center" valign="top" rowspan="1" colspan="1">6.57 (1.15)</td><td align="center" valign="top" rowspan="1" colspan="1">10.90 (1.43)</td><td align="center" valign="top" rowspan="1" colspan="1">19.89 (7.41)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">360/2580</td><td align="center" valign="top" rowspan="1" colspan="1">294/2575</td><td align="center" valign="top" rowspan="1" colspan="1">270/2577</td><td align="center" valign="top" rowspan="1" colspan="1">226/2578</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0010" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.94 (0.81, 1.10)</td><td align="center" valign="top" rowspan="1" colspan="1">0.94 (0.81, 1.11)</td><td align="center" valign="top" rowspan="1" colspan="1">0.90 (0.76, 1.07)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0011" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.93 (0.79, 1.10)</td><td align="center" valign="top" rowspan="1" colspan="1">0.92 (0.76, 1.10)</td><td align="center" valign="top" rowspan="1" colspan="1">0.91 (0.72, 1.16)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0012" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 (0.81, 1.13)</td><td align="center" valign="top" rowspan="1" colspan="1">0.95 (0.79, 1.14)</td><td align="center" valign="top" rowspan="1" colspan="1">0.93 (0.73, 1.18)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Free choline</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/d</td><td align="center" valign="top" rowspan="1" colspan="1">27.48 (6.49)</td><td align="center" valign="top" rowspan="1" colspan="1">44.27 (4.65)</td><td align="center" valign="top" rowspan="1" colspan="1">63.73 (6.94)</td><td align="center" valign="top" rowspan="1" colspan="1">121.21 (65.90)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">300/2578</td><td align="center" valign="top" rowspan="1" colspan="1">297/2577</td><td align="center" valign="top" rowspan="1" colspan="1">273/2577</td><td align="center" valign="top" rowspan="1" colspan="1">280/2578</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0010" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.98 (0.83, 1.15)</td><td align="center" valign="top" rowspan="1" colspan="1">0.87 (0.74, 1.03)</td><td align="center" valign="top" rowspan="1" colspan="1">0.81 (0.69, 0.95)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0011" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">1.03 (0.87, 1.22)</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.81, 1.16)</td><td align="center" valign="top" rowspan="1" colspan="1">1.01 (0.83, 1.22)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0012" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">1.08 (0.91, 1.27)</td><td align="center" valign="top" rowspan="1" colspan="1">0.99 (0.82, 1.19)</td><td align="center" valign="top" rowspan="1" colspan="1">1.02 (0.84, 1.23)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Glycerophosphocholine</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/day</td><td align="center" valign="top" rowspan="1" colspan="1">8.49 (1.89)</td><td align="center" valign="top" rowspan="1" colspan="1">13.55 (1.41)</td><td align="center" valign="top" rowspan="1" colspan="1">19.71 (2.33)</td><td align="center" valign="top" rowspan="1" colspan="1">39.87 (24.53)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">354/2578</td><td align="center" valign="top" rowspan="1" colspan="1">277/2577</td><td align="center" valign="top" rowspan="1" colspan="1">272/2577</td><td align="center" valign="top" rowspan="1" colspan="1">247/2578</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0010" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 (0.69, 0.94)</td><td align="center" valign="top" rowspan="1" colspan="1">0.79 (0.67, 0.92)</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 (0.68, 0.94)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0011" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 (0.82, 1.14)</td><td align="center" valign="top" rowspan="1" colspan="1">1.03 (0.86, 1.23)</td><td align="center" valign="top" rowspan="1" colspan="1">1.05 (0.85, 1.29)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0012" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 (0.81, 1.13)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (0.83, 1.19)</td><td align="center" valign="top" rowspan="1" colspan="1">1.10 (0.89, 1.35)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Phosphocholine</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/day</td><td align="center" valign="top" rowspan="1" colspan="1">2.85 (0.86)</td><td align="center" valign="top" rowspan="1" colspan="1">5.13 (0.60)</td><td align="center" valign="top" rowspan="1" colspan="1">7.38 (0.76)</td><td align="center" valign="top" rowspan="1" colspan="1">12.53 (4.27)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">321/2578</td><td align="center" valign="top" rowspan="1" colspan="1">277/2577</td><td align="center" valign="top" rowspan="1" colspan="1">290/2577</td><td align="center" valign="top" rowspan="1" colspan="1">262/2578</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0010" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.93 (0.79, 1.09)</td><td align="center" valign="top" rowspan="1" colspan="1">1.04 (0.88, 1.22)</td><td align="center" valign="top" rowspan="1" colspan="1">0.99 (0.84, 1.17)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0011" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">1.06 (0.90, 1.26)</td><td align="center" valign="top" rowspan="1" colspan="1">1.18 (0.99, 1.40)</td><td align="center" valign="top" rowspan="1" colspan="1">1.07 (0.89, 1.29)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0012" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">1.06 (0.90, 1.25)</td><td align="center" valign="top" rowspan="1" colspan="1">1.20 (1.00, 1.42)</td><td align="center" valign="top" rowspan="1" colspan="1">1.14 (0.95, 1.38)</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Betaine</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean intake (SD), mg/day</td><td align="center" valign="top" rowspan="1" colspan="1">20.24 (12.66)</td><td align="center" valign="top" rowspan="1" colspan="1">66.50 (12.40)</td><td align="center" valign="top" rowspan="1" colspan="1">115.94 (17.54)</td><td align="center" valign="top" rowspan="1" colspan="1">251.19 (108.38)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Events/participants</td><td align="center" valign="top" rowspan="1" colspan="1">301/2578</td><td align="center" valign="top" rowspan="1" colspan="1">289/2577</td><td align="center" valign="top" rowspan="1" colspan="1">278/2577</td><td align="center" valign="top" rowspan="1" colspan="1">282/2578</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 1<xref rid="jcsm13796-note-0010" ref-type="table-fn">
<sup>a</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">1.03 (0.87, 1.21)</td><td align="center" valign="top" rowspan="1" colspan="1">1.02 (0.86, 1.20)</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.82, 1.14)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 2<xref rid="jcsm13796-note-0011" ref-type="table-fn">
<sup>b</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">1.05 (0.88, 1.24)</td><td align="center" valign="top" rowspan="1" colspan="1">1.12 (0.94, 1.33)</td><td align="center" valign="top" rowspan="1" colspan="1">1.09 (0.91, 1.31)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Model 3<xref rid="jcsm13796-note-0012" ref-type="table-fn">
<sup>c</sup>
</xref>, HR (95% CI)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">0.99 (0.83, 1.17)</td><td align="center" valign="top" rowspan="1" colspan="1">1.05 (0.88, 1.25)</td><td align="center" valign="top" rowspan="1" colspan="1">0.98 (0.81, 1.18)</td></tr></tbody></table><table-wrap-foot id="jcsm13796-ntgp-0004"><fn id="jcsm13796-note-0010"><label>
<sup>a</sup>
</label><p>The crude model was not adjusted for any confounders.</p></fn><fn id="jcsm13796-note-0011"><label>
<sup>b</sup>
</label><p>Adjusted for age (years, continuous), sex (female or male), nationality (Han or minority), residence (urban or rural), geographical region (northeastern China, eastern China, central China, southern China or southwestern China), marital status (married, single, or divorced, widowed or separated), education (at or below primary school, middle school, or at or above high school), household per capita annual income (CNY, continuous), medical insurance (yes or no), drinking (never, moderate or excess), smoking (never, previous or current), drinking water source (tap water, well water or other), cooking fuel type (clean fuel or polluting fuel), sedentary behaviour (hours/day, continuous), dietary intake of energy (kcal/day, continuous), protein (g/day, continuous), fat (g/day, continuous) and carbohydrate (g/day, continuous).</p></fn><fn id="jcsm13796-note-0012"><label>
<sup>c</sup>
</label><p>Additionally adjusted for body mass index (kg/m<sup>2</sup>, continuous), hypertension (yes or no), health infrastructure score (continuous), sanitation score (continuous) and social services score (continuous).</p></fn></table-wrap-foot></table-wrap><p>We also examined the association of choline intake from different food sources with incident pre&#x02010;frailty and frailty. We found that major food groups providing choline were eggs (63.71&#x02009;mg/day) and vegetables and fruits (50.75&#x02009;mg/day) (Figure&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S3</xref>). Consumption in the 3rd quartiles of choline from plant&#x02010;derived sources had lower frailty risks with HRs of 0.83 (95% CI: 0.69, 0.99) compared with the 1st quartile (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S6</xref>). No statistically significant association was observed between choline from animal&#x02010;derived sources and incident pre&#x02010;frailty or frailty.</p></sec><sec id="jcsm13796-sec-0015"><label>3.3</label><title>Subgroups and Sensitivity Analyses</title><p>We performed subgroup analyses according to sex, age and energy intake (Tables&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S7&#x02013;S9</xref>). Notably, we observed that energy intake exhibits an interaction effect on (pre&#x02010;) frailty (<italic toggle="yes">p</italic>&#x02009;=&#x02009;0.0377) (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S9</xref>). The sensitivity analyses for frailty were consistent with primary findings after adjusting for multiple variables (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S10</xref>). The findings persisted with additional adjustments for survey years in each model. Additionally, the associations of total choline with frailty were further reinforced by excluding participants within the first 2 and 4&#x02009;years of follow&#x02010;up or with (pre&#x02010;) frailty at baseline (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S10</xref>). The HRs (95% CI) only had minor variations after the energy adjustment model calibrated the total choline intake for frailty (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S10</xref>). Moreover, further adjustment for lipid profiles yielded only minimal changes in the outcomes (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S10</xref>).</p></sec></sec><sec sec-type="discussion" id="jcsm13796-sec-0016"><label>4</label><title>Discussion</title><p>In this prospective, household&#x02010;based cohort study using data from CHNS, we observed L&#x02010;shaped associations between total choline intake and the odds of incident pre&#x02010;frailty and frailty. Analysis of choline&#x02010;contributing compounds revealed that phosphatidylcholine intake was negatively associated with increased odds of pre&#x02010;frailty and frailty, while sphingomyelin intake was associated with pre&#x02010;frailty and combined (pre&#x02010;) frailty. Betaine intake was found to be linked to reduced odds of pre&#x02010;frailty. Furthermore, lipid&#x02010;soluble choline intake was associated with lower odds of incident pre&#x02010;frailty and frailty, whereas moderate intake of water&#x02010;soluble choline demonstrated associations with pre&#x02010;frailty and (pre&#x02010;) frailty. Notably, plant&#x02010;derived sources of choline were significantly associated with a reduced odds of incident frailty. These findings provide epidemiological evidence supporting dietary strategies for the prevention and management of frailty in adults, underscoring its public health significance.</p><p>Choline plays a pivotal role in numerous fundamental physiological functions throughout the human life cycle and is recognized as an essential dietary nutrient [<xref rid="jcsm13796-bib-0025" ref-type="bibr">25</xref>]. Previous studies have demonstrated an inverse association between choline intake and adverse health&#x02010;related outcomes, including cardiovascular disease, osteoporosis and other conditions [<xref rid="jcsm13796-bib-0026" ref-type="bibr">26</xref>, <xref rid="jcsm13796-bib-0027" ref-type="bibr">27</xref>]. Lee et&#x000a0;al. aimed to examine the relationship between total dietary choline intake and muscle responses to resistance exercise training (RET) in older adults with healthy conditions (<italic toggle="yes">n</italic>&#x02009;=&#x02009;46) [<xref rid="jcsm13796-bib-0028" ref-type="bibr">28</xref>]. They subsequently conducted a randomized controlled trial (<italic toggle="yes">n</italic>&#x02009;=&#x02009;37) and verified that low total choline intake may negatively affect strength gains with RET [<xref rid="jcsm13796-bib-0029" ref-type="bibr">29</xref>]. Mone et&#x000a0;al. conducted a randomized controlled trial (<italic toggle="yes">n</italic>&#x02009;=&#x02009;99) focusing on cognitive frailty in hypertensive older adults, examining the effects of choline bitartrate combined with vitamin B<sub>12</sub> on cognitive impairment [<xref rid="jcsm13796-bib-0030" ref-type="bibr">30</xref>]. These studies offer preliminary insights into the relationship between choline and frailty, but they are limited by small sample sizes and short&#x02010;term designs. Our research extends this body of knowledge by developing a FI, primarily based on the principle of cumulative deficits, which includes 27 items to reflect overall health status rather than focusing on individual dimensions such as muscle strength or cognition. Additionally, we conducted a comprehensive cohort study in Chinese adults, examining the association between dietary choline, its derivatives, soluble forms, food sources and frailty. Our findings indicated that participants with a moderate to high intake of total choline showed a lower risk of incident frailty. Furthermore, our results remained statistically significant after excluding participants who experienced an outcome within the first 4&#x02009;years of follow&#x02010;up. The outcomes of our study substantiate the viewpoint of choline as an independent preventive factor for frailty.</p><p>We also investigated the relationship between the intake of different forms of soluble choline and its subtypes with incident frailty. Our study demonstrated that the consumption of lipid&#x02010;soluble choline is significantly associated with a reduced risk of frailty, and phosphatidylcholine is associated with a decreased risk of frailty. As a primary source of dietary choline, phosphatidylcholine has been shown in an RCT study to improve muscle health, mainly due to its role in maintaining cell membrane integrity and promoting muscle function [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S11</xref>]. Phosphatidylcholine serves as a precursor to phosphatidic acid, which is crucial for activating mammalian target of rapamycin (mTOR), a key regulator of protein synthesis that promotes muscle growth and repair. Thus, adequate intake of phosphatidylcholine may indirectly enhance muscle quality [<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S12</xref>]. Additionally, prior studies of metabolomic profile and dietary patterns have shown that phosphatidylcholine is significantly associated with the Mediterranean dietary pattern (MD) [<xref rid="jcsm13796-bib-0031" ref-type="bibr">31</xref>]. One meta&#x02010;analysis has indicated that adherence to MD could significantly mitigate the risk of frailty [<xref rid="jcsm13796-bib-0032" ref-type="bibr">32</xref>].</p><p>Interestingly, we found that plant&#x02010;derived choline, but not animal&#x02010;derived choline, significantly reduced the odds of frailty. Our results indicated that the primary dietary sources of plant&#x02010;derived choline include vegetables, fruits, potatoes, beans, nuts and grains. Plant&#x02010;derived diets are rich in diverse nutrients that may synergize with choline to enhance its protective effects against frailty. Thus, the inverse association observed may partly reflect contributions from other beneficial components in these foods. Choline may influence protein homeostasis by increasing synthesis and reducing breakdown. Evidence suggests a negative association between plant protein intake and frailty, highlighting the potential synergistic effects of plant&#x02010;derived choline and protein in enhancing muscle health [<xref rid="jcsm13796-bib-0033" ref-type="bibr">33</xref>]. A cohort study among Chinese elderly reported that a healthful plant&#x02010;derived diet was associated with decreased frailty risk [<xref rid="jcsm13796-bib-0010" ref-type="bibr">10</xref>], consistent with findings from a study of elderly American women [<xref rid="jcsm13796-bib-0034" ref-type="bibr">34</xref>]. These findings support the role of plant&#x02010;derived diets in frailty prevention and suggest that the protective effects of choline may be influenced by its specific form and dietary source rather than choline alone. Future studies should explore the metabolic mechanisms of different choline types and sources and their associations with frailty.</p><p>Frailty is an age&#x02010;related syndrome characterized by a decline in multiple system functions, leading to physical weakness, reduced mobility and decreased resistance to disease [<xref rid="jcsm13796-bib-0035" ref-type="bibr">35</xref>]. The potential protective role of choline against frailty may be attributed to several mechanisms. Firstly, choline is essential for muscle health as it serves as a precursor to acetylcholine, a critical neurotransmitter for muscle signal transmission [<xref rid="jcsm13796-bib-0036" ref-type="bibr">36</xref>]. A deficiency in choline may impair muscle function and strength, thereby contributing to the development of frailty [<xref rid="jcsm13796-bib-0037" ref-type="bibr">37</xref>]. Secondly, choline aids in lipid metabolism and the prevention of hepatic steatosis. The accumulation of fat in the liver and the presence of metabolic disorders have been associated with the onset of frailty [<xref rid="jcsm13796-bib-0038" ref-type="bibr">38</xref>]. Thirdly, choline is involved in modulating inflammatory responses within the body. Frailty is often accompanied by chronic low&#x02010;grade inflammation, and sufficient choline intake may help regulate the immune function and reduce inflammation, thereby mitigating frailty symptoms [<xref rid="jcsm13796-bib-0039" ref-type="bibr">39</xref>]. Additionally, choline acts as a methyl donor and participates in various methylation reactions that are crucial for DNA repair, gene expression and detoxification processes [<xref rid="jcsm13796-bib-0040" ref-type="bibr">40</xref>]. Poor methylation can lead to a variety of health issues, including frailty.</p><sec id="jcsm13796-sec-0017"><label>4.1</label><title>Strengths and Limitations</title><p>This study has several strengths, including its prospective design, large sample size, and comprehensive range of choline intake data. The detailed information enabled us to examine choline derivatives, different soluble forms and food sources, which are often overlooked in other studies.</p><p>There are also several limitations in this study. Firstly, dietary choline intake is assessed using three consecutive 24h&#x02010;DRs, which are susceptible to measurement error and may not accurately reflect long&#x02010;term choline intake. However, we incorporated two weekdays and one weekend day to investigate dietary patterns that closely approximate the habitual intake of the study participants. Secondly, our study outcome is primarily concerned with the incident frailty. However, given that frailty is a dynamic and modifiable process, further research could explore the association between choline and changes in frailty status. Thirdly, similar to other traditional observational cohort studies, despite our adjustment for multiple confounders, the potential for confounding bias might remain, such as genetic susceptibility. Fourthly, our study only focused on the Chinese population, which may restrict the generalizability of findings to other ethnic and racial demographics. Lastly, lipid profiles were only collected in the 2009 survey wave (Table&#x000a0;<xref rid="jcsm13796-supitem-0001" ref-type="supplementary-material">S11</xref>), limiting their use as a covariate throughout the study period. However, sensitivity analyses using imputed lipid data yielded results consistent with the main analysis, while findings from the 2009 dataset showed slight attenuation.</p></sec></sec><sec sec-type="conclusions" id="jcsm13796-sec-0018"><label>5</label><title>Conclusions</title><p>In conclusion, moderate to high dietary choline intake (171.00&#x02013;464.99&#x02009;mg/day), particularly phosphatidylcholine (145.20&#x02013;304.93&#x02009;mg/day), may be associated with reduced odds of frailty.</p></sec><sec sec-type="COI-statement" id="jcsm13796-sec-0020"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="jcsm13796-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Figure S1.</bold> Flowchart of recruitment and follow&#x02010;up.</p><p>
<bold>Figure S2.</bold> Dose&#x02010;respond associations of choline&#x02010;contributing compounds and betaine intake with incident frailty.</p><p>
<bold>Figure S3.</bold> Distribution of total choline intake from various food sources.</p><p>
<bold>Table&#x000a0;S1.</bold> The 27 items and cut&#x02010;points for the frailty index.</p><p>
<bold>Table&#x000a0;S2.</bold> Baseline characteristics of participants by quartiles of total choline intake.</p><p>
<bold>Table&#x000a0;S3.</bold> Associations of lipid&#x02010; and water&#x02010;soluble choline intake with incident pre&#x02010;frailty and frailty.</p><p>
<bold>Table&#x000a0;S4.</bold> Associations of choline&#x02010;contributing compounds and betaine intake with incident pre&#x02010;frailty.</p><p>
<bold>Table&#x000a0;S5.</bold> Associations of choline&#x02010;contributing compounds and betaine intake with incident (pre&#x02010;) frailty.</p><p>
<bold>Table&#x000a0;S6.</bold> Associations of choline intake from different food sources with incident pre&#x02010;frailty and frailty.</p><p>
<bold>Table&#x000a0;S7.</bold> Associations of total choline intake with incident frailty: subgroup analysis stratified by sex, age and energy intake.</p><p>
<bold>Table&#x000a0;S8.</bold> Associations of total choline with incident pre&#x02010;frailty: subgroup analysis stratified by sex, age and energy intake.</p><p>
<bold>Table&#x000a0;S9.</bold> Associations of total choline intake with incident (pre&#x02010;) frailty: subgroup analysis stratified by sex, age and energy intake.</p><p>
<bold>Table&#x000a0;S10.</bold> Associations of total choline intake with incident frailty: sensitivity analysis.</p><p>
<bold>Table&#x000a0;S11.</bold> Characteristics of participants for lipid profiles.</p></caption><media xlink:href="JCSM-16-e13796-s001.docx"/></supplementary-material></sec></body><back><ack id="jcsm13796-sec-0019"><title>Acknowledgements</title><p>This research uses data from the China Health and Nutrition Survey (CHNS). We thank the National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention; the Carolina Population Center (5 R24 HD050924), University of North Carolina at Chapel Hill; the National Institutes of Health (R01&#x02010;HD30880, DK056350, R24 HD050924 and R01&#x02010;HD38700); and the Fogarty International Center, National Institutes of Health (5D43TW007709 and 5D43TW009077) for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys; and the China&#x02010;Japan Friendship Hospital, Ministry of Health, for support for CHNS 2009.</p></ack><sec sec-type="data-availability" id="jcsm13796-sec-0022"><title>Data Availability Statement</title><p>Study protocol: Not available. Statistical code: Not available. Data set: Available from the China Health and Nutrition Survey on request (<ext-link xlink:href="https://www.cpc.unc.edu/projects/china" ext-link-type="uri" specific-use="software is-supplemented-by">https://www.cpc.unc.edu/projects/china</ext-link>).</p></sec><ref-list content-type="cited-references" id="jcsm13796-bibl-0001"><title>References</title><ref id="jcsm13796-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0001">
<string-name>
<given-names>C.</given-names>
<surname>Casals</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>&#x000c1;vila&#x02010;Cabeza&#x02010;de&#x02010;Vaca</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Gonz&#x000e1;lez&#x02010;Mariscal</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Effects of an Educational Intervention on Frailty Status, Physical Function, Physical Activity, Sleep Patterns, and Nutritional Status of Older Adults With Frailty or Pre&#x02010;Frailty: The FRAGSALUD Study</article-title>,&#x0201d; <source>Frontiers in Public Health</source>
<volume>11</volume> (<year>2023</year>): <elocation-id>1267666</elocation-id>.<pub-id pub-id-type="pmid">38098822</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0002">
<string-name>
<given-names>R.</given-names>
<surname>O'Caoimh</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Sezgin</surname>
</string-name>, <string-name>
<given-names>M. R.</given-names>
<surname>O'Donovan</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Prevalence of Frailty in 62 Countries Across the World: A Systematic Review and Meta&#x02010;Analysis of Population&#x02010;Level Studies</article-title>,&#x0201d; <source>Age and Ageing</source>
<volume>50</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>96</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">33068107</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0003">
<string-name>
<given-names>E.</given-names>
<surname>Dent</surname>
</string-name>, <string-name>
<given-names>F. C.</given-names>
<surname>Martin</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Bergman</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Woo</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Romero&#x02010;Ortuno</surname>
</string-name>, and <string-name>
<given-names>J. D.</given-names>
<surname>Walston</surname>
</string-name>, &#x0201c;<article-title>Management of Frailty: Opportunities, Challenges, and Future Directions</article-title>,&#x0201d; <source>Lancet</source>
<volume>394</volume>, no. <issue>10206</issue> (<year>2019</year>): <fpage>1376</fpage>&#x02013;<lpage>1386</lpage>.<pub-id pub-id-type="pmid">31609229</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0004">
<string-name>
<given-names>W.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Ruan</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Peng</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Lu</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Wang</surname>
</string-name>, &#x0201c;<article-title>Associations of Depression, Sleep Disorder With Total and Cause&#x02010;Specific Mortality: A Prospective Cohort Study</article-title>,&#x0201d; <source>Journal of Affective Disorders</source>
<volume>298</volume>, no. <issue>Pt A</issue> (<year>2022</year>): <fpage>134</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">34763200</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0005">
<string-name>
<given-names>C.</given-names>
<surname>de Labra</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Guimaraes&#x02010;Pinheiro</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Maseda</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Lorenzo</surname>
</string-name>, and <string-name>
<given-names>J. C.</given-names>
<surname>Mill&#x000e1;n&#x02010;Calenti</surname>
</string-name>, &#x0201c;<article-title>Effects of Physical Exercise Interventions in Frail Older Adults: A Systematic Review of Randomized Controlled Trials</article-title>,&#x0201d; <source>BMC Geriatrics</source>
<volume>15</volume> (<year>2015</year>): <elocation-id>154</elocation-id>.<pub-id pub-id-type="pmid">26626157</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0006">
<string-name>
<given-names>H. J.</given-names>
<surname>Coelho&#x02010;Junior</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Marzetti</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Picca</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Cesari</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Uchida</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Calvani</surname>
</string-name>, &#x0201c;<article-title>Protein Intake and Frailty: A Matter of Quantity, Quality, and Timing</article-title>,&#x0201d; <source>Nutrients</source>
<volume>12</volume>, no. <issue>10</issue> (<year>2020</year>): <elocation-id>2915</elocation-id>.<pub-id pub-id-type="pmid">32977714</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0007">
<string-name>
<given-names>U.</given-names>
<surname>Kansakar</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Trimarco</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Mone</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Varzideh</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Lombardi</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Santulli</surname>
</string-name>, &#x0201c;<article-title>Choline Supplements: An Update</article-title>,&#x0201d; <source>Frontiers in Endocrinology</source>
<volume>14</volume> (<year>2023</year>): <elocation-id>1148166</elocation-id>.<pub-id pub-id-type="pmid">36950691</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0008">
<string-name>
<given-names>J.</given-names>
<surname>Yuan</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Liu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Is Dietary Choline Intake Related to Dementia and Alzheimer's Disease Risks? Results From the Framingham Heart Study</article-title>,&#x0201d; <source>American Journal of Clinical Nutrition</source>
<volume>116</volume>, no. <issue>5</issue> (<year>2022</year>): <fpage>1201</fpage>&#x02013;<lpage>1207</lpage>.<pub-id pub-id-type="pmid">37208066</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0009">
<string-name>
<given-names>M.</given-names>
<surname>Golzarand</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Bahadoran</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Mirmiran</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Azizi</surname>
</string-name>, &#x0201c;<article-title>Dietary Choline and Betaine Intake and Risk of Hypertension Development: A 7.4&#x02010;Year Follow&#x02010;Up</article-title>,&#x0201d; <source>Food &#x00026; Function</source>
<volume>12</volume>, no. <issue>9</issue> (<year>2021</year>): <fpage>4072</fpage>&#x02013;<lpage>4078</lpage>.<pub-id pub-id-type="pmid">33977970</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0010">
<string-name>
<given-names>R.</given-names>
<surname>Qi</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Sheng</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>X.</given-names>
<surname>Zhang</surname>
</string-name>, &#x0201c;<article-title>Plant&#x02010;Based Diet Indices and Their Association With Frailty in Older Adults: A CLHLS&#x02010;Based Cohort Study</article-title>,&#x0201d; <source>Nutrients</source>
<volume>15</volume>, no. <issue>24</issue> (<year>2023</year>): <elocation-id>5120</elocation-id>.<pub-id pub-id-type="pmid">38140379</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0011">
<string-name>
<given-names>M.</given-names>
<surname>Yan</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Wu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Association Between Dietary Purine Intake and Mortality: Evidence From the CHNS Cohort Study</article-title>,&#x0201d; <source>Nutrients</source>
<volume>14</volume>, no. <issue>9</issue> (<year>2022</year>): <elocation-id>1718</elocation-id>.<pub-id pub-id-type="pmid">35565687</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0012">
<string-name>
<given-names>F.</given-names>
<surname>Zhai</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>B. M.</given-names>
<surname>Popkin</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Evaluation of the 24&#x02010;Hour Individual Recall Method in China</article-title>,&#x0201d; <source>Food and Nutrition Bulletin</source>
<volume>17</volume>, no. <issue>2</issue> (<year>1996</year>): <fpage>1</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="jcsm13796-bib-0013"><label>13</label><mixed-citation publication-type="miscellaneous" id="jcsm13796-cit-0013">
<string-name>
<given-names>K. B. S.</given-names>
<surname>Patterson</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Williams</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Howe</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Holden</surname>
</string-name>, &#x0201c;<article-title>USDA Database for the Choline Content of Common Foods</article-title>,&#x0201d; Release Two, <year>2008</year>, <ext-link xlink:href="http://www.ars.usda.gov/SP2UserFiles/Place/80400525/Data/Choline/Choln02.pdf" ext-link-type="uri">http://www.ars.usda.gov/SP2UserFiles/Place/80400525/Data/Choline/Choln02.pdf</ext-link>.</mixed-citation></ref><ref id="jcsm13796-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0014">
<string-name>
<given-names>S. H.</given-names>
<surname>Zeisel</surname>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Mar</surname>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Howe</surname>
</string-name>, and <string-name>
<given-names>J. M.</given-names>
<surname>Holden</surname>
</string-name>, &#x0201c;<article-title>Concentrations of Choline&#x02010;Containing Compounds and Betaine in Common Foods</article-title>,&#x0201d; <source>Journal of Nutrition</source>
<volume>133</volume>, no. <issue>5</issue> (<year>2003</year>): <fpage>1302</fpage>&#x02013;<lpage>1307</lpage>.<pub-id pub-id-type="pmid">12730414</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0015">
<string-name>
<given-names>H. J.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Kang</surname>
</string-name>, <string-name>
<given-names>Y. Z.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Relationship Between Different Forms of Dietary Choline and Ovarian Cancer Survival: Findings From the Ovarian Cancer Follow&#x02010;Up Study, a Prospective Cohort Study</article-title>,&#x0201d; <source>Food &#x00026; Function</source>
<volume>13</volume>, no. <issue>23</issue> (<year>2022</year>): <fpage>12342</fpage>&#x02013;<lpage>12352</lpage>.<pub-id pub-id-type="pmid">36354156</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0016">
<string-name>
<given-names>A. B.</given-names>
<surname>Mitnitski</surname>
</string-name>, <string-name>
<given-names>A. J.</given-names>
<surname>Mogilner</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Rockwood</surname>
</string-name>, &#x0201c;<article-title>Accumulation of Deficits as a Proxy Measure of Aging</article-title>,&#x0201d; <source>Scientific World Journal</source>
<volume>1</volume> (<year>2001</year>): <fpage>323</fpage>&#x02013;<lpage>336</lpage>.<pub-id pub-id-type="pmid">12806071</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0017">
<string-name>
<given-names>K.</given-names>
<surname>Rockwood</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>MacKnight</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A Global Clinical Measure of Fitness and Frailty in Elderly People</article-title>,&#x0201d; <source>CMAJ</source>
<volume>173</volume>, no. <issue>5</issue> (<year>2005</year>): <fpage>489</fpage>&#x02013;<lpage>495</lpage>.<pub-id pub-id-type="pmid">16129869</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0018">
<string-name>
<given-names>D.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Changes in Frailty and Incident Cardiovascular Disease in Three Prospective Cohorts</article-title>,&#x0201d; <source>European Heart Journal</source>
<volume>45</volume>, no. <issue>12</issue> (<year>2024</year>): <fpage>1058</fpage>&#x02013;<lpage>1068</lpage>.<pub-id pub-id-type="pmid">38241094</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0019">
<string-name>
<given-names>J. N.</given-names>
<surname>Fan</surname>
</string-name>, <string-name>
<given-names>Z. J.</given-names>
<surname>Sun</surname>
</string-name>, <string-name>
<given-names>C. Q.</given-names>
<surname>Yu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Comparison of Fried Phenotype and Frailty Index and Their Associations With Risk of Mortality</article-title>,&#x0201d; <source>Zhonghua Liu Xing Bing Xue Za Zhi</source>
<volume>42</volume>, no. <issue>7</issue> (<year>2021</year>): <fpage>1179</fpage>&#x02013;<lpage>1187</lpage>.<pub-id pub-id-type="pmid">34814528</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0020">
<string-name>
<given-names>X. M.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>W. F.</given-names>
<surname>Zhong</surname>
</string-name>, <string-name>
<given-names>Z. H.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Dietary Diversity and Frailty Among Older Chinese People: Evidence From the Chinese Longitudinal Healthy Longevity Study</article-title>,&#x0201d; <source>American Journal of Clinical Nutrition</source>
<volume>117</volume>, no. <issue>2</issue> (<year>2023</year>): <fpage>383</fpage>&#x02013;<lpage>391</lpage>.<pub-id pub-id-type="pmid">36811562</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0021">
<string-name>
<given-names>K.</given-names>
<surname>Jayanama</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Theou</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Blodgett</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Cahill</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Rockwood</surname>
</string-name>, &#x0201c;<article-title>Frailty, Nutrition&#x02010;Related Parameters, and Mortality Across the Adult Age Spectrum</article-title>,&#x0201d; <source>BMC Medicine</source>
<volume>16</volume>, no. <issue>1</issue> (<year>2018</year>): <elocation-id>188</elocation-id>.<pub-id pub-id-type="pmid">30360759</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0022">
<string-name>
<given-names>J. L.</given-names>
<surname>Atkins</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Jylh&#x000e4;v&#x000e4;</surname>
</string-name>, <string-name>
<given-names>N. L.</given-names>
<surname>Pedersen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A Genome&#x02010;Wide Association Study of the Frailty Index Highlights Brain Pathways in Ageing</article-title>,&#x0201d; <source>Aging Cell</source>
<volume>20</volume>, no. <issue>9</issue> (<year>2021</year>): <elocation-id>e13459</elocation-id>.<pub-id pub-id-type="pmid">34431594</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0023">
<string-name>
<given-names>J.</given-names>
<surname>Blodgett</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Theou</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Kirkland</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Andreou</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Rockwood</surname>
</string-name>, &#x0201c;<article-title>The Association Between Sedentary Behaviour, Moderate&#x02010;Vigorous Physical Activity and Frailty in NHANES Cohorts</article-title>,&#x0201d; <source>Maturitas</source>
<volume>80</volume>, no. <issue>2</issue> (<year>2015</year>): <fpage>187</fpage>&#x02013;<lpage>191</lpage>.<pub-id pub-id-type="pmid">25542406</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0024">
<string-name>
<given-names>J.</given-names>
<surname>Gao</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Yang</surname>
</string-name>, and <string-name>
<given-names>Q.</given-names>
<surname>Xiao</surname>
</string-name>, &#x0201c;<article-title>Life Expectancy Among Older Adults With or Without Frailty in China: Multistate Modelling of a National Longitudinal Cohort Study</article-title>,&#x0201d; <source>BMC Medicine</source>
<volume>21</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>101</elocation-id>.<pub-id pub-id-type="pmid">36927351</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0025">
<string-name>
<given-names>S. H.</given-names>
<surname>Zeisel</surname>
</string-name> and <string-name>
<given-names>K. A.</given-names>
<surname>da Costa</surname>
</string-name>, &#x0201c;<article-title>Choline: An Essential Nutrient for Public Health</article-title>,&#x0201d; <source>Nutrition Reviews</source>
<volume>67</volume>, no. <issue>11</issue> (<year>2009</year>): <fpage>615</fpage>&#x02013;<lpage>623</lpage>.<pub-id pub-id-type="pmid">19906248</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0026">
<string-name>
<given-names>R.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Yue</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Association Between Dietary Choline Intake and Cardiovascular Diseases: National Health and Nutrition Examination Survey 2011&#x02013;2016</article-title>,&#x0201d; <source>Nutrients</source>
<volume>15</volume>, no. <issue>18</issue> (<year>2023</year>): <elocation-id>4036</elocation-id>.<pub-id pub-id-type="pmid">37764819</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0027">
<string-name>
<given-names>Y. W.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>P. P.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>Y. J.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Low Dietary Choline Intake Is Associated With the Risk of Osteoporosis in Elderly Individuals: A Population&#x02010;Based Study</article-title>,&#x0201d; <source>Food &#x00026; Function</source>
<volume>12</volume>, no. <issue>14</issue> (<year>2021</year>): <fpage>6442</fpage>&#x02013;<lpage>6451</lpage>.<pub-id pub-id-type="pmid">34076003</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0028">
<string-name>
<given-names>C. W.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Galvan</surname>
</string-name>, <string-name>
<given-names>T. V.</given-names>
<surname>Lee</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Low Intake of Choline Is Associated With Diminished Strength and Lean Mass Gains in Older Adults</article-title>,&#x0201d; <source>Journal of Frailty &#x00026; Aging</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>78</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">36629089</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0029">
<string-name>
<given-names>C. W.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>T. V.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Galvan</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Effect of Choline and Resistance Training on Strength and Lean Mass in Older Adults</article-title>,&#x0201d; <source>Nutrients</source>
<volume>15</volume>, no. <issue>18</issue> (<year>2023</year>): <elocation-id>3874</elocation-id>.<pub-id pub-id-type="pmid">37764658</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0030">
<string-name>
<given-names>P.</given-names>
<surname>Mone</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Trimarco</surname>
</string-name>, <string-name>
<given-names>U.</given-names>
<surname>Kansakar</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Izzo</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Santulli</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Trimarco</surname>
</string-name>, &#x0201c;<article-title>Combining Choline Bitartrate and Vitamin B12 Ameliorates Cognitive Impairment in Hypertensive Elders With Cognitive Frailty</article-title>,&#x0201d; <source>Pharmacological Research</source>
<volume>201</volume> (<year>2024</year>): <elocation-id>107103</elocation-id>.<pub-id pub-id-type="pmid">38336310</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0031">
<string-name>
<given-names>T.</given-names>
<surname>Tanaka</surname>
</string-name>, <string-name>
<given-names>S. A.</given-names>
<surname>Talegawkar</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Jin</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Metabolomic Profile of Different Dietary Patterns and Their Association With Frailty Index in Community&#x02010;Dwelling Older Men and Women</article-title>,&#x0201d; <source>Nutrients</source>
<volume>14</volume>, no. <issue>11</issue> (<year>2022</year>): <elocation-id>2237</elocation-id>.<pub-id pub-id-type="pmid">35684039</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0032">
<string-name>
<given-names>N.</given-names>
<surname>Rashidi Pour Fard</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Amirabdollahian</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Haghighatdoost</surname>
</string-name>, &#x0201c;<article-title>Dietary Patterns and Frailty: A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Nutrition Reviews</source>
<volume>77</volume>, no. <issue>7</issue> (<year>2019</year>): <fpage>498</fpage>&#x02013;<lpage>513</lpage>.<pub-id pub-id-type="pmid">31038679</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0033">
<string-name>
<given-names>T.</given-names>
<surname>Tanaka</surname>
</string-name>, <string-name>
<given-names>J. K.</given-names>
<surname>Das</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Jin</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Plant Protein but Not Animal Protein Consumption Is Associated With Frailty Through Plasma Metabolites</article-title>,&#x0201d; <source>Nutrients</source>
<volume>15</volume>, no. <issue>19</issue> (<year>2023</year>): <elocation-id>4193</elocation-id>.<pub-id pub-id-type="pmid">37836476</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0034">
<string-name>
<given-names>M.</given-names>
<surname>Sotos&#x02010;Prieto</surname>
</string-name>, <string-name>
<given-names>E. A.</given-names>
<surname>Struijk</surname>
</string-name>, <string-name>
<given-names>T. T.</given-names>
<surname>Fung</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Association Between the Quality of Plant&#x02010;Based Diets and Risk of Frailty</article-title>,&#x0201d; <source>Journal of Cachexia, Sarcopenia and Muscle</source>
<volume>13</volume>, no. <issue>6</issue> (<year>2022</year>): <fpage>2854</fpage>&#x02013;<lpage>2862</lpage>.<pub-id pub-id-type="pmid">36177985</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0035">
<string-name>
<given-names>Y.</given-names>
<surname>Yuan</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Lin</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Association of Triglyceride&#x02010;Glucose Index Trajectory and Frailty in Urban Older Residents: Evidence From the 10&#x02010;Year Follow&#x02010;Up in a Cohort Study</article-title>,&#x0201d; <source>Cardiovascular Diabetology</source>
<volume>22</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>264</elocation-id>.<pub-id pub-id-type="pmid">37775740</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0036">
<string-name>
<given-names>I. H.</given-names>
<surname>Ulus</surname>
</string-name> and <string-name>
<given-names>R. J.</given-names>
<surname>Wurtman</surname>
</string-name>, &#x0201c;<article-title>Choline Increases Acetylcholine Release</article-title>,&#x0201d; <source>Lancet</source>
<volume>1</volume>, no. <issue>8533</issue> (<year>1987</year>): <fpage>624</fpage>.</mixed-citation></ref><ref id="jcsm13796-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0037">
<string-name>
<given-names>A.</given-names>
<surname>Moretti</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Paoletta</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Liguori</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Bertone</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Toro</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Iolascon</surname>
</string-name>, &#x0201c;<article-title>Choline: An Essential Nutrient for Skeletal Muscle</article-title>,&#x0201d; <source>Nutrients</source>
<volume>12</volume>, no. <issue>7</issue> (<year>2020</year>): <elocation-id>2144</elocation-id>.<pub-id pub-id-type="pmid">32708497</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0038">
<string-name>
<given-names>K. D.</given-names>
<surname>Corbin</surname>
</string-name> and <string-name>
<given-names>S. H.</given-names>
<surname>Zeisel</surname>
</string-name>, &#x0201c;<article-title>Choline Metabolism Provides Novel Insights Into Nonalcoholic Fatty Liver Disease and Its Progression</article-title>,&#x0201d; <source>Current Opinion in Gastroenterology</source>
<volume>28</volume>, no. <issue>2</issue> (<year>2012</year>): <fpage>159</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">22134222</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0039">
<string-name>
<given-names>Y.</given-names>
<surname>Qiu</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Hou</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Supplemental Choline Modulates Growth Performance and Gut Inflammation by Altering the Gut Microbiota and Lipid Metabolism in Weaned Piglets</article-title>,&#x0201d; <source>Journal of Nutrition</source>
<volume>151</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>20</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">33245135</pub-id>
</mixed-citation></ref><ref id="jcsm13796-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jcsm13796-cit-0040">
<string-name>
<given-names>Z. S.</given-names>
<surname>Choline</surname>
</string-name>, &#x0201c;<article-title>Other Methyl&#x02010;Donors and Epigenetics</article-title>,&#x0201d; <source>Nutrients</source>
<volume>9</volume>, no. <issue>5</issue> (<year>2017</year>): <elocation-id>445</elocation-id>.<pub-id pub-id-type="pmid">28468239</pub-id>
</mixed-citation></ref></ref-list></back></article>